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INTRODUCTION 
Heart disease in pregnancy is one among the major medical 
problems complicating pregnancy. Heart disease ranks third among 
the most common causes of maternal mortality. Obstetric 
haemorrhage is the first and pre eclampsia is the second most common 
causes of maternal mortality. When a patient with heart disease 
becomes pregnant, the already diseased heart is overloaded due to the 
haemodynamic changes that occur in pregnancy and this poses a risk 
on the maternal and fetal health and the maternal fetal prognosis 
become poor. This emphasises the importance of pre-conceptional 
counselling in a patient with heart disease and termination of 
pregnancy at the earliest in patients with high risk heart disease. 
As obstetricians we face the challenge of preventing pregnancy, 
which is an added burden on the already diseased heart from hastening 
the rate of decline of patient’s general condition.  
Patients with poorly compensated heart disease were strongly 
discouraged from conceiving in the past. Nowadays comprehensive 
cardiac care and obstetric care including infertility treatment have 
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improved tremendously and this helps the patients with heart disease 
to undergo a safe pregnancy and delivery. 
In a developing country like India even now rheumatic heart 
disease is the most common cardiac lesion seen in association with 
pregnancy. 
Pregnancy in patients with heart disease requires comprehensive 
healthcare to be given by obstetricians, cardiologists, anaesthetists and 
paediatricians. 
And especially obstetricians are in a position to make crucial 
decisions to provide a good maternal and perinatal outcome. 
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AIM OF STUDY 
1. To analyse the impacts of heart disease on pregnancy. 
2. To study the impacts of pregnancy on heart disease. 
3. To analyse the possible prognostic factors which facilitate 
formulation of guidelines for a safe motherhood. 
4. To study the maternal and perinatal outcome. 
5. To study the role of medical termination of pregnancy and 
permanent method of sterilisation in patients with heart disease. 
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REVIEW OF LITERATURE 
A historical study conducted by Hamilton and Thompson at the 
Boston lying in hospital between 1921 and 1938 was the first ever 
study on heart disease complicating pregnancy. 
The first ever study in India was conducted in mid 1950s by 
Sudhir Bose from Calcutta and by Masoni from Bombay. They were 
followed by a number of studies and these studies were carried out in 
India as well as in other countries. With the available data from these 
studies the incidence of heart disease in pregnancy ranges from 0.2 to 
0.97%1.   
In the United States of America, the incidence of heart diseases 
of rheumatic origin has declined considerably and the incidence is 
almost Nil2. However the incidence of congenital heart diseases and 
the heart diseases of other origin like ischemic heart disease, 
cardiomyopathies, pulmonary hypertension etc. has increased in a 
significant manner. 
The first ever largest study on heart disease complicating 
pregnancy was conducted during the period between 1942 and 1971 
by Szekely and Snaith.  Nearly a thousand patients suffering from 
various types of heart diseases, who were admitted in New Castle 
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General Hospital, were observed in this study4. The report of this 
study was that the incidence of rheumatic heart disease has declined 
remarkably over the past three decades. In this study, Mitral stenosis 
continued to be the dominant lesion with an incidence of 90%. 15.4% 
of these patients under study developed pulmonary congestion and 
1.6% of these patients developed pulmonary oedema. Heart failure 
complicated 1.8% of the patients. Maternal mortality was 1.6% and 
the major cause of death was acute pulmonary oedema. 
In 1970, a study conducted on 1192 patients with rheumatic 
heart disease and congenital heart disease in the Queen Charlotte 
Hospital by Barnes during a 20 year period from 1947 to 1966 
reported that rheumatic heart disease was seen in 88.2% of the study 
population and congenital heart disease in 11.8% of the study 
population indicating that rheumatic heart disease is the most common 
type of heart disease. 
Meyer and colleagues conducted a study over one decade and 
reported in1994 which stated that, of the 74 patients with heart disease 
complicating pregnancy studied during this period only a few patients 
gave a positive history of Rheumatic fever. 
Bitsch and colleagues in 1989 and Mcfaul et al in 1988 
conducted various studies on antenatal mothers with heart disease and 
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reported that over 50% of the study population was suffering from 
congenital heart disease. In a study by Tan and De Swiet5 reported in 
1998 conducted on 73 women, the results showed that in only 12% of 
study population the cardiac disease is of Rheumatic origin. 
Brickner and colleagues in 2200 reported that with the 
advancements in the surgical techniques and improvements in the 
medical management, there is a significant increase in the number of 
women with congenital heart disease reaching child bearing age. 
According to Sach et al (1988)6, the maternal mortality due to 
heart disease was 0.3 to 5.6 per lakh live births in a study conducted 
from 1954 to 1985. Heart disease has been reported as the cause of 
maternal death in 8.5% cases in a study conducted between 1968 and 
1993 by Ayhan et al (1994)7,8. According to Martin and associates 
(1999), Heart disease remains to be the third leading cause of death 
after haemorrhage and anaemia. 
HAEMODYNAMIC CHANGES IN PREGNANCY 
A plethora of studies conducted by numerous authors have 
made extensive contributions which made us to understand the 
hemodynamic changes in pregnancy. The most important of these 
studies was the one conducted by Clark and associates in 1989. In this 
study, 10 healthy primigravidae were included and cardiac 
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catheterisation on the right side of the heart was performed from 35 to 
38 weeks of gestation and also at 11 to 13 weeks after delivery. This 
study contributed extensively in defining the normal haemodynamic 
values in late pregnancy. 
A study conducted by Katz and associates (1978)9, which made 
use of echocardiography, was done in normal pregnant women and 
these patients were again subjected to echocardiography in the 
postpartum period. Riccarda Del Bere and associates reported in 
200110, about a study conducted on the effects of posture on the 
haemodynamics and cardiac output and these parameters were 
measured in normal pregnant women in all the three trimesters of 
pregnancy, 3 months before delivery during labour and 6 months 
postpartum in their supine and standing postures.11 
PARAMET
ER 
MODIFICA
TION 
MAGNI
TUDE PEAK 
REFERENC
E 
Oxygen 
consumption 
(VO2) 
 
 
+20% 
+40% to 
60% 
Term Gemzell,1957 
Permoll,1975 
Oxygen 
delivery 
 
700-
1400ml/m
in 
Term Hankins,1996 
Blood 
volume 
Plasma 
volume 
 
 
+45% to 
50% 
 
32week
s 
 
McLennon,19
48 
 
Red cells 
  
+25% to 
 
30-32 
 
Jepson,1968 
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32% weeks Letsky,1995 
Total body 
water  
 
+6 – 8 
litre 
 
Term 
Scitchilk,196
7 
Lindheimer1
973 
Resistance 
changes 
Systemic 
circulation 
 
 
 
 
 
-2% 
 
 
 
16-24 
Weeks 
 
 
Bader,1955 
 
Pulmonary 
circulation  
-34% 34week
s 
Kitabatake,19
83 
Clark,1989 
Blood 
pressure 
(SVR & CO) 
Systolic 
 
 
 
-9% 
 
 
25week
s 
 
 
Wilson,1980 
 
Diastolic 
 
(Slightly 
more on 
diastolic) 
  
Myocardial 
contractility 
Chronotropis
m (HR) 
 
 
 
+20% to 
30% 
 
 
 
Term 
 
 
 
Wilson,1980 
 
Inotropism 
(SV)  
 
+11% to 
32% 
 
Term 
 
Mabie,1994 
Robson,1989 
Cardiac 
output 
(HR×SV)  
+30% to 
50% 
Term Gemsell,1957 
Hendricks,19
58 
Ucland,1969 
Robson,1989 
Van 
Oppen,1996 
 
Uteroplacent
al circulation 
 
+> 100% Term Metcalfe,195
5 
Assail,1960 
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:  MARKED INCREASE 
:  INCREASE 
 
:  DECREASE 
:  NO CHANGE 
SVR :  SYSTEMIC VASCULAR  RESISTANCE 
CO : CARDIAC OUTPUT 
 
DIAGNOSIS OF HEART DISEASE IN PREGNANCY 
In a normal pregnant patient, the cardiovascular system 
undergoes drastic changes and this makes the diagnosis of heart 
disease more complicated in pregnant patient. The normal structural 
and functional changes that usually occur in pregnancy can give rise to 
signs and symptoms that mimic a heart disease. Otherwise, these 
changes can also conceal an existing heart disease.  MetCalfe and 
associates (1986), devised a few clinical indicators of heart disease in 
pregnancy. Elkayam and GllicheeN(1990)12 outlined a few symptoms 
and signs suggestive of cardiac disease in pregnancy.  With the help of 
these formulations, supported by investigations like ECG and 
  
Fig1: apical four-chamber view
 
 
Fig 2: Two-dimensional echocardiogram (parasternal four chamber) 
showing a dilated, thinned left ventricle (LV).
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echocardiography, the diagnosis of organic lesions of heart in a 
pregnancy turns out to be simple. 
Limachar and co-workers (1985)13 conducted studies on 
pregnant women employing two dimensional echo and pulsed  
Doppler echo. 
CLINICAL CLASSIFICATION 
The first ever classification for the assessment of functional 
capacity was published in1928 by the New York Heart Association14 
and it has been revised for the 8th time in 1979.one important change 
was the addition of assessment of cardiac status after all data have 
been reviewed. Thus the classification no linger based on symptoms 
alone. 
Classification of the functional capacity recommended by the 
New York Heart Association (used for classification of dyspnoea due 
to heart failure) 
Class I: Patients with cardiac disease, but without resulting limitation 
of physical activity. Ordinary physical activity does not cause undue 
fatigue, palpitation, dyspnoea, or anginal pain.
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Class II: Patients with cardiac disease resulting in slight limitation of 
physical activity. They are comfortable at rest. Ordinary physical 
activity results in fatigue, palpitation, dyspnoea, or anginal pain. They 
are comfortable at rest. Less than ordinary activity causes fatigue, 
palpitation, dyspnoea, or anginal pain. 
Class III:  Patients with marked limitation of physical activity. 
Class IV: Patients with cardiac disease resulting in inability to carry 
on any physical activity without discomfort. Symptoms of heart 
failure or of the anginal syndrome may be present even at rest. If any 
physical activity is undertaken, discomfort is increased. 
PRECONCEPTIONAL COUNSELLING 
The entity of pre-conceptional counselling turn out to be noteworthy 
when a patient with severely compromised or a high risk heart disease 
wishes to conceive. The American College of Obstetricians and 
Gynaecologists (1992)16 had implemented the three tier system of 
classification in pregnancy according to the risk of death in pregnancy. 
This helps to counsel the women regarding the appropriateness of 
conception and or continuation of pregnancy. The risk of death in  
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RISK FOR MATERNAL MORTALITY CAUSED BY VARIOUS 
HEART DISEASES15 
GROUP RISK MORTALITY 
ROUP 1 
MINIMAL RISK 
Atrial septal defect 
Ventricular septal defect 
Patent ductusarteriosus 
Pulmonary or Tricuspid disease 
Tetralogy of Fallot corrected 
Bioprosthetic valve 
Mitral stenosis NYHA class I & II 
 
0.1% 
GROUP 2 
MODERATE RISK 
Mitral stenosis NYHA class III & IV 
Aortic stenosis 
Coarctation of aorta without valvular involvement 
Tetralogy of Fallot uncorrected  
Previous myocardial infarction 
Marfan’s syndrome with normal aorta 
5 -15% 
GROUP 2B 
Mitral stenosis with atrial fibrillation 
Artificial valve 
 
GROUP 3 
MAJOR RISK 
Pulmonary hypertension 
Coarctation of aorta with valvular involvement 
Marfan’s syndrome with aortic involvement 
Eisenmenger’s syndrome 
Peripartum cardiomyopathy 
25 -50% 
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pregnant patients with heart disease was also published by Clark and 
co-workers in 1997. 
RHEUMATIC HEART DISEASE 
According to Carabello and Crawfird (1997) this might also 
result in the development of passive pulmonary hypertension and 
fixed cardiac output. According to a study conducted by Caulin Glaser 
and Setaco (1999) 2.5% of pregnant women with mitral stenosis 
develop congestive cardiac failure for the first time in pregnancy. 
A study published by Desai and associates (2000)17 stated that 
pregnant patients with Mitral Stenosis develop symptoms only when 
the diameter of mitral valve orifice is < 2.5 cm2. Once these patients 
go into labour, adequate pain relief, comfortable back rest and 
anxiolytic measures become mandatory to prevent the development of 
congestive cardiac failure in these patients. 
Epidural analgesia during labour is ideal for pain relief. 
Rational use of intra-venous fluids at the rate 75ml/hr prevents volume 
overload. Clark and colleagues in 198518 proposed a hypothesis which 
stated that the rise in the pulmonary capillary wedge pressure in the 
immediate postpartum period is a result of loss of resistance in 
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placental circulation and increase in the venous return from the lower 
limbs, pelvic veins and postpartum uterus which is an example for the 
state of auto transfusion. Sudden increase in the preload leads to the 
rise of pulmonary capillary wedge pressure and the patient develops 
pulmonary edema19. This strongly supports the concept of rational use 
of intravenous fluids and hence volume overload can be 
prevented(Ramin and Gilstrap in1999). 
Aortic stenosis is the second most common cardiac lesion to be 
diagnosed after mitral stenosis. The haemodynamic abnormalities are 
the consequences of fixed cardiac output seen in the patients with 
aortic stenosis. Certain issues we come across in a pregnant patient 
including blood loss during delivery, regional analgesia in labour, and 
venocaval compression by the gravid uterus further more decrease the 
preload and worsens the state of fixed cardiac output. Lao and co-
workers in 1993 reported 7% of collective mortality in patients with 
severe form of aortic stenosis. 
Amongst the fairly well tolerated cardiac lesions in pregnancy 
lie the mitral valve incompetence and the aortic valve insufficiency. 
Decrease in the vascular resistance during pregnancy reduces the 
severity of these lesions. This concept was proposed by MC Anulty 
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and associates in 1988 and also by Mendelson and Lang in 1998. 
Occurrence of mitral and aortic valve incompetence has been 
associated with the use of fenfluramine, which is an appetite 
suppressant. This has been hypothesized based on the results of 
various conducted by Gardin et al in 2000, Pick et al in 1998 and 
Khan et al in 1998. 
 
CONGENITAL HEART DISEASE 
In the western countries, the ratio of congenital and rheumatic 
heart disease has undergone a change over the past five decades. 
Patients with small to moderate shunt lesions (left to right), VSD, 
ASD and PDA tolerate pregnancy well. According to Perloff20 (1997) 
80-85% of adults with significant congenital heart disease have 
undergone some kind of surgical intervention in childhood. 
Women who suffer from a cyanotic congenital heart disease 
perform poorly in pregnancy, particularly in patients with uncorrected 
Tetralogy of Fallot the maternal mortality reach up to 10%21. Sawney 
and co-workers in 1999 published a report which states that still birth 
occurs in 14% and fetal growth restriction occurs in 36% of patients.
  
 
Fig 3: Normal Aortic Valve
 
 
 
 
 
 
 
Fig 4: Bicuspid Aortic Valve
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Zuber and associates (1999) 22reported favourable outcomes in 
19 pregnant patients with Fallot’s tetralogy24 and the patients selected 
for this study had a good ventricular systolic function and favourable 
functional class in pregnancy. Siggn et al in 1999 reported that 
patients who underwent surgical correction of Tetralogy of Fallot25 
before pregnancy showed a fairly good outcome in pregnancy. 
Connolly and associates (1999)23 published that patients who had 
already undergone surgical correction of TGA in childhood have 
favourable outcome in pregnancy. 
As per the report given by Perloff, the incidence of pulmonary 
stenosis in general population is 10% and pregnancy is well tolerated 
by women with these stenotic lesions. In women below 30 years of 
age, the most probable cause of aortic stenosis is the presence of 
Bicuspid aortic valve26.  The average life expectancy in a patient with 
Aortic Stenosis once the patient develops exertional dyspnoea is only 
5 years27. Development of symptoms in a patient with aortic stenosis 
is an indication for valve replacement. As a general rule, balloon 
valvotomy28 in these patients with aortic valve disease is not 
performed as the rate of occurrence of serious complications is nearly
  
 
Fig 5: pathogenesis in Tetralogy of Fallot 
 
Fig 6: large atrial septal defect in MRI
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10% and the complications include stroke, aortic rupture, aortic valve 
insufficiency and finally death. (Carebello and Gawrod, 1997). When 
the patients with aortic stenosis go into labour and delivery, they 
should be managed on the wet side with IV fluid infusion at the rate of 
125 to 150 ml/hr29. 
Whitmore and colleagues(1982), and Shimi and associates 
(1987) proposed that the inheritance of congenital heart disease in the 
off springs born to mothers suffering from congenital heart disease is 
5 to 10%. 
ELLIS-VAN CREVELD SYNDROME 
Ellis-van Creveld syndrome30 ( six–fingered dwarfism / digital 
integer deficiency) is a condition which includes a number of 
anomalies including post-axial polydactyly, congenital heart defects 
(most commonly an atrial septal defect producing a common atrium, 
occurring in 60% of affected individuals), pre-natal tooth eruption, 
fingernail dysplasia, short-limbed dwarfism, short ribs, cleft palate, 
and malformation of the wrist bones31.Thissyndrome occurs in 1 in 
60,000 to 200,000 newborns. It has an autosomal recessive 
inheritance. This syndrome is the result of a mutation in the EVC gene 
and EVC2 gene32. 
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MISCELLANEOUS HEART DISEASES 
PULMONARY HYPERTENSION (PHT) 
According to Weiss and co-workers (1998), the maternal 
mortality rate in patients with pulmonary hypertension is 30%33. Also 
in patients with pulmonary hypertension, that occur secondary to 
cardiac or pulmonary diseases or recurrent pulmonary emboli or drug 
abuse, maternal mortality is significant. 
Eden borough and associates (2000) published a report which 
states that the prognosis of patients with cystic fibrosis34 becomes poor 
once they develop complications like pulmonary hypertension and 
corpulmonale. And these patients are at greatest risk during labour and 
delivery, as the venous return and in turn the right ventricular filling is 
lessened and this is linked to majority of the maternal deaths.  
Easter ling and colleagues (1999) used nifedipine and 
prostacycline infusion in pregnancy with success. Weiss and 
associates (2000) reported that a patient with severe pulmonary 
hypertension underwent a successful caesarean section under epidural 
analgesia. 
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MITRAL VALVE PROLAPSE 
It is a connective tissue disorder and is most often inherited and 
is seen in 15% of otherwise healthy young women. Pathology of this 
condition is that there is myxomatous degeneration of the valve 
leaflets, annulus and chordate tendinae. These patients have a 
favourable pregnancy outcome35 (Chia and co-workers, 1994). 
Patients with regurgitant lesions require antibiotic prophylaxis against 
infective endocarditis according to Degani and associates (1989). 
DISEASE OF AORTA 
Marfan’s syndrome36 and coarctation of aorta are the 
pathological conditions of aorta we are more concerned about in a 
pregnant patient. They are associated with a greater risk of aortic 
dissection. According to Pepin and associates (2000) the rate of 
occurrence of aortic dissection and aortic rupture was more in patients 
with Ehler-Danlos syndrome37. According to a report published by 
Simpson and D.A.Hon (1997), 50% of the aortic dissections that occur 
in women less than 40 years of age occur in late pregnancy. 
  
 
Fig7:Magnetic resonance imaging scan of a 34
severe coarctation of the aorta (near interruption), with multiple and 
very large collateral vessels.
 
 
-year
 
-old with 
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Easter ling and associates (1991) reported that in a normal 
pregnant women the aortic diameter increases considerably during  
pregnancy and this much more enhanced in case of a women with 
preeclampsia. The most important complications associated with the 
coarctation of aorta are congestive cardiac failure, infective 
endocarditis of the accompanying bicuspid aortic valve and the most 
dangerous complication is aortic rupture. McAnulty and 
associates(1990) reported 3% maternal mortality. Coarctation of aorta 
is inherited in 2% of off springs. 
SURGICALLY CORRECTED HEART DISEASE 
Morris and Menashe (1991) conducted a retrospective study in 
Oregan from 1958 to 198938 and reported that out of the 2700 children 
who underwent corrective cardiac surgery during childhood, more 
than 75% reached the reproductive age group. Perloff39 (1997) gave a 
report which states that only 15 to 20% of patients with congenital 
heart disease had not undergone any previous surgical intervention. 
Congenital cardiac lesions that remain undiagnosed until adulthood 
are Atrial Septal Defect, Pulmonary Stenosis, Bicuspid Aortic Valve 
and Coarctation of Aorta as per the reports of Brickner and co-workers 
(2000). 
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VALVE REPLACEMENT 
Nargorney and Field in 1981 reported favourable outcomes in 
pregnant patients who underwent replacement of even upto three 
valves. Sharouni and Doakley (1994) have published their experience 
in treating 150 pregnant women with prosthetic valves. Chan and 
colleagues40,55 (2000) reassessed 28 studies reported upto 1997 and 
came to a conclusion that  continued use of warfarin during pregnancy 
is linked with a good maternal outcome. Nevertheless the rate of 
occurrence of embryopathy was 6.4%.  Fortunately heparin 
substitution during the period of organogenesis eliminated 
embryopathy41. However the use of heparin in pregnancy is related to 
considerable increase in the rate of occurrence of thromboembolic 
complications. 
Low dose heparin is shown to be inadequate42,54  and one study 
conducted  by IturbeAlerris and associates(1986) showed that out of 
the 35 women taking heparin, 3 women developed massive 
thrombosis resulting in death in 2 of these patients. Chan and 
associates in 2000 reported a maternal mortality rate of 2.9% in these 
patients. Lee and coworkers (1994) reported a favourable outcome in 
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95 pregnant women and 57 of these women had a porcine graft  and 4 
patients out of these 57 patients developed dysfunction of valves. 
CARDIAC SURGERY IN PREGNANCY 
Pavan Kumar and associates (1988) published a study which 
reported the results of closed mitral valve commissurotomy in 
pregnancy.  Many similar studies42 had been conducted worldwide and 
the overall perinatal mortality was 7% and there was no maternal 
death during the procedure. 
Of late, percutaneous transcatheter balloon valvotomy44 of the 
mitral valve in pregnancy is being performed and revealed good 
results in the study published by Gupta et al (1998) and by Caulin, 
Glaser and Setaco (1999). 
The first ever case of open heart surgery45 with 
cardiopulmonary bypass performed on a pregnant patient was reported 
by Layse and associates in 1958. Neiss and associates (1998) reviewed 
the studies conducted in 70 patients. 59 out of these 70 patients 
underwent cardiopulmonary bypass surgery during pregnancy 
following which 6% maternal death and 30% perinatal death has been 
recorded. 
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In the present-day, concurrent caesarean section and open heart 
surgery is being performed once term pregnancy is reached. 
Birincioglu and associates (1999) published a report on six women 
who underwent mitral valve replacement in combination with 
caesarean section46. 
PREGNANCY SUBSEQUENT TO HEART 
TRANSPLANTATION 
Lowenstein et al reported a first ever case of fruitful pregnancy 
in a patient who had already undergone heart transplantation. Key and 
co-workers (1989) and Kim and associates as well conducted an 
exhaustive data that reported that the transplanted heart in the pregnant 
patients reacted well to the haemodynamic changes that normally 
occur in pregnancy47). Troche and associates (1998) reported about 
10 pregnancies and Dashe and co-workers (1998) reported about 29 
pregnancies in patients following heart transplant and there was no 
maternal death directly due to obstetric cause48. 
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PERIPARTUM CARDIOMYOPATHY 
Peripartum cardiomyopathy49 is a idiopathic cardiomyopathy 
that is defined as deterioration in cardiac function presenting typically 
between the last month of pregnancy and up to five months 
postpartum. PPCM is a form of dilated cardiomyopathy. Fatkin and 
associates (1999), reported that inheritance of idiopathic 
cardiomyopathy occurs in nearly one third of the cases. The patient is 
considered to have PPCM when all the causes of heart failure are 
excluded according to Broan and Bertelet (1998)50 and Hibhaw and 
co-workers (1999)51. Ford and associates reported good prognosis in 
women with idiopathic cardiomyopathy i.e., PPCM. According to 
Lampert and colleagues (1997)52,53, 50% of women diagnosed to have 
peripartum cardiomyopathy regained their normal left ventricular 
function within 6 months of diagnosis. 
INFECTIVE ENDOCARDITIS 
Infective endocarditis is not common during pregnancy and 
puerperium. According to Cox and colleagues (1988), the incidence of 
infective endocarditis in pregnancy is 1 in 16,000 deliveries.  Cox and 
Leveno (1989) reported that the overall maternal mortality. 
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CONTRACEPTION IN CARDIAC PATIENTS 
Contraception in heart patients is very important as these should 
limit their family size and complete their families before there is 
serious cardiac decompensation56. There are a few choices of 
temporary methods of contraception left for these patients        
(Pearse,1984). Oral contraceptives carry the risk of 
hypercoagulability, thromboembolism, hypertension and 
hyperlipidemia. IUCD carry the risk of vasovagal syncope due to pain 
at the time of insertion of the device and infection. Vasovagal syncope 
can be prevented by using smaller sized Copper-T and infection can 
be prevented by giving prophylactic antibiotics (Brenner 1975). 
Conventional barrier methods of contraception such as condoms, 
diaphragms, and foams are safe but have a high failure rates. 
Low dose oral contraceptive pills are safe and preferable to 
IUCD. After the completion of family, permanent method of 
contraception is recommended in these patients57. 
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MATERIALS AND METHODS 
The study of maternal and perinatal outcome in heart disease 
complicating pregnancy was conducted in the Institute of Obstetrics 
and Gynaecology, Egmore, Chennai. This study was performed during 
the period between January 2011 and July 2012 for 18 months and a 
total of 302 cases heart disease complicating pregnancy were included 
in the study. 
METHODOLOGY 
Methodology included 
(i) Meticulous history taking including significant 
history of Rheumatic Fever 
(ii) History of decompensation in  preceding 
pregnancies 
(iii) Details of the heart disease 
(iv) Details of medical and surgical treatment of Heart 
Disease 
(v) A methodical clinical examination 
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INCLUSION CRITERIA: 
All pregnant women with various Heart Disease                             
(Rheumatic, Congenital, Valvular, Ischemic etc.,) who attends OPD in 
IOG, Egmore. Pregnant patients with heart disease who are admitted 
for safe confinement and pregnant patients with heart disease who 
undergo MTP 
EXCLUSION CRTERIA: 
All pregnant women without any Heart Disease, all heart 
disease patients with pregnancy who have abortions, vesicular mole, 
blighted ovum and heart disease patients who get admitted for reasons 
other than safe confinement. All antenatal women who were 
diagnosed to have a Heart Disease and women who had undergone 
surgeries for the heart disease were involved in this study. 
All pregnant women who donot have heart disease but 
presenting with symptoms and signs suggestive of heart disease were 
subjected to meticulous history taking and detailed examination and 
cardiologist opinion was obtained for these patients and the patients 
newly diagnosed to have a heart disease were included in the study. 
Echocardiogram was beneficial in diagnosing an organic lesion of the 
heart. 
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Once a clinical diagnosis was achieved, these patients were 
subjected to a series of investigations including complete blood count, 
random blood sugar, renal function and liver function tests and 
urinalysis to diagnose and treat anaemia and urinary tract infection. 
All patients were subjected to Electrocardiogram and Echocardiogram. 
Patients were categorised according to NEWYORK HEART 
ASSOCIATION classification and dealt withaccordingly. 
ROUTINE MANAGEMENT 
Antenatal women diagnosed to have a definitive heart disease 
were admitted first for thorough evaluation and the clinical grading of 
the patients’ functional status was made. If the patient fall into the 
functional class I and II, they were discharged and advised to attend 
the antenatal OPD regularly. The cardiac status of the patient 
determines the frequency of the antenatal visits. These women were 
counselled regarding the importance of adequate rest, and were 
instructed to avoid heavy work, emotional stress, and to consume a 
high calorie, salt restricted diet. 
Anaemia, once diagnosed, was corrected in early pregnancy 
without delay. Infections, if present, were vigorously treated with the 
appropriate antibiotics. Benzathine penicillin prophylaxis was 
LA 
 
RA 
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routinely given for patients with rheumatic heart disease as per 
cardiologist’s advice and these patients were sent for periodic 
cardiologist review. Patient presenting with features of 
decompensation, at any trimester, were hospitalised immediately and 
treated as per cardiologist’s advice.  Otherwise patients were routinely 
admitted from 32 to 34 weeks for safe confinement. 
Patients with decompensated heart were admitted in Intensive 
Care Unit and provided strict bed rest, oxygen, diuretics and digoxin. 
If the patient is put on long term digoxin and diuretics, potassium 
supplement in the form of KCl syrup was given for fear of 
hypokalemia. 
MANAGEMENT OF LABOUR 
The main principle behind the obstetric management of 
antenatal patients with heart disease is to wait for the spontaneous 
onset of labour. When the patients go into labour, they were taken care 
of in propped up position and provided oxygen by mask. Patients were 
sedated in the latent phase of first stage of labour with an intravenous 
line. Prophylactic antibiotics were recommended in all these patients. 
If the patient is on diuretics, digoxin and deriphylline, the drugs are 
continued or else started as per cardiologists’ advice. 
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Epidural analgesia is given as a routine for all heart disease 
patients when they enter active phase of first stage of labour and once 
they enter the second stage of labour, it is cut short by prophylactic 
outlet forceps delivery with episiotomy. Episiotomies and other 
perineal lacerations were sutured promptly. 
Caesarean section was carried out only for obstetric indications. 
When the patient is under epidural analgesia, caesarean is performed 
with epidural top-up. After delivery, for 24 to 48 hours they were 
monitored for signs of postpartum haemorrhage and decompensation 
and were kept in Intensive Care Unit. For a minimum of 5 days, 
patients were kept in ICU and then stepped down to next level of care 
in labour ward before they were sent to complicated post natal ward. 
Neonates were followed up throughout their hospital stay by 
neonatologist. Breast feeding is recommended all patients except in 
those with grade IV heart failure. 
All patients were counselled regarding the need of 
contraception and the risk of future pregnancies. Primigravidae were 
instructed to space their pregnancies for atleast two years and then to 
complete their family with no delay. Patients who had completed the 
family and also patients who suffered from severe decompensation in 
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this pregnancy were effectively counselled to undergo puerperal 
sterilisation. If the cardiac high for anaesthesia and surgery is high the 
patient’s husband were counselled for vasectomy. Puerperal 
sterilisation was performed usually 2 weeks after delivery once the 
symptoms and signs of heart failure had subsided.Copper-T was 
inserted in the patients who had notcompleted their family. IUCD 
insertion is carried out under sterile aseptic precautions and a course 
of antibiotics was given. 
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OBSERVATION AND RESULTS 
The present study was conducted in the INSTITUTE OF 
OBSTETRICS AND GYNAECOLOGY for a period of 18 months 
from January-2011 to June- 2012 among the antenatal patients with 
heart disease. During the study period, total number pregnant patients 
with heart disease complicating pregnancy who were included in the 
study were 338 patients. Out of these 338 patients 302 patients 
delivered and 36 underwent MTP. 
TABLE 1  
TOTAL NO. OF CARDIAC 
PATIENTS 
TOTAL NO. OF 
DELIVERIES 
TOTAL NO. 
OF MTP 
338 302 36 
 
There were a total of 21,269 deliveries in IOG out of which 302 
deliveries were of patients with heart disease. 
TABLE 2 
TOTAL NO. OF 
DELIVERIES 
HEART DISEASE 
DELIVERIES 
INCIDENCE OF 
HEART DISEASE 
21,269 302 1.41% 
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DISTRIBUTION OF CASES AS PER PURPOSE OF ADMISSION 
TABLE 3 
PURPOSE OF 
ADMISSION 
TOTAL NO. OF 
PATIENTS 
PERCENTAGE 
DELIVERY 302 89.35% 
MTP 36 
 
10.65% 
 
URBAN – RURAL DISTRIBUTION 
The distribution of the patients according to their residential 
address was studied. 64.8% were from urban areas and 35.2% were 
from rural areas. 
TABLE 4 
TOTAL NO. OF 
PATIENTS 
NO.OF PATIENTS  FROM 
URBAN AREAS 
INCIDENCE 
338 219 64.8% 
TABLE 5 
TOTAL NO. OF 
PATIENTS 
NO. OF PATIENTS FROM 
RURAL AREAS 
INCIDENCE 
338 119 35.2% 
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SOCIO-ECONOMIC STATUS DISTRIBUTION 
TABLE 6 
SOCIO ECONOMIC    
CLASS 
NO.OF CASES PERCENTAGE 
I 0 0 
II 1 0.3% 
III 37 10.94% 
IV 165 48.82% 
V 135 39.94% 
TOTAL 338 100% 
 
BOOKED STATUS 
302 patients were admitted for safe confinement. Out of the 
total 302 cases, 290 (96.03%) cases were booked cases and 12 cases 
(3.97%) were unbooked cases. All the unbooked cases were 
multigravida and 4 of them were diagnosed to have heart disease only 
in this pregnancy 
All the unbooked cases were multigravida and 4 of them were 
diagnosed to have heart disease only in this pregnancy. One patient 
 35 
 
was a grand multigravida who is G8P5L5A2 who is a construction site 
worker and was diagnosed to have severe MSwith moderate 
pulmonary hypertension only in this pregnancy and was referred to 
our institute. 
3 patients were in congestive cardiac failure at the time of admission 
and 2 out of 3 these developed atrial fibrillation.in one of these 
patients Lower respiratory tract infection was the precipitating factor 
for heart disease. All were treated with anti-failure drugs. One neonate 
was admitted in neonatal intensive care unit for respiratory distress 
syndrome. There was no maternal or perinatal mortality among the 
unbooked cases . 
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AGE DISTRIBUTION - TABLE 7 
AGE (YEARS) 
NO. OF 
CASES 
PERCENTAGE 
≤ 19 15 4.44% 
20-24 173 51.18% 
25-29 119 35.20% 
30-34 18 5.33% 
≥ 35 13 3.85% 
TOTAL 338 100% 
 
PARITY WISE DISTRIBUTION - TABLE 8 
GRAVIDA NO. OF CASES PERCENTAGE 
PRIMI 146 43.2% 
2nd GRAVIDA 121 35.8% 
3rd GRAVIDA 55 16.3% 
4th GRAVIDA 10 2.9% 
GRAND 
MULTIGRAVIDA 
6 1.8% 
TOTAL 338 100% 
 
 37 
 
DIAGNOSIS OF HEART DISEASE 
Among the study group, 22.78% of the heart diseases were 
diagnosed for the first time in pregnancy and 77.22% of the patients 
were already diagnosed to have heart diseases before pregnancy. Out 
of the 22.78% of the patients diagnosed in this pregnancy 40% were 
diagnosed only they were evaluated for cardiac symptoms and 60% 
were diagnosed during the routine echocardiogram done in the 
antenatal patients. 
The practice of obtaining a cardiologist opinion for all the 
antenatal patients is now being followed in the Government heath 
posts and the Government corporation hospitals in and around 
Chennai. And because of this many patients with MVPS with or 
without valvular dysfunction with deterioration in their functional 
status are being diagnosed during pregnancy. 
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DISTRIBUTION OF TYPE OF HEART DISEASE 
TABLE 9 
TYPE OF HEART DISEASE 
NO.OF 
CASES 
PERCENTA
GE 
RHEUMATIC 165 48.81% 
CONGENITAL 99 29.29% 
MITRAL VALVE PROLAPSE 
SYNDROME 
52 15.39% 
PRIMARY PULMONARY 
HYPERTENSION 
6 1.78% 
CARDIOMYOPATHY 9 2.66% 
OTHERS 7 2.07% 
TOTAL 338 100% 
 
Other types of heart disease include sick sinus syndrome 
(1case), heart block (4 cases), viral myocarditis (1 case), constrictive 
pericarditis (1 case). 
DISTRIBUTION OF CASES OF RHEUMATIC ETIOLOGY 
The following table shows the distribution of the various types 
of valvular lesions in patients with rheumatic heart disease. 58 patients 
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had isolated mitral stenosis with or without pulmonary hypertension. 
32 patients had isolated mitral regurgitation with or without 
pulmonary hypertension. 29 patients had mitral stenosis with mitral 
regurgitation. 39 patients had combined lesions ie.,stenotic and/ or 
regurgitation of more than one heart valve ie., mitral, aortic, tricuspid 
and pulmonary. 3 patients had rheumatic aortic stenosis. 2 patients had 
rheumatic aortic regurgitation. 4 patients had rheumatic aortic stenosis 
with regurgitation. 
TABLE 10 
TYPE OF LESION NO.OF CASES PERCENTAGE 
MS ONLY 58 35.15% 
MR ONLY 32 19.39% 
MS WITH MR 29 17.59% 
MULTIVALVULAR 
LESIONS 
37 22.42% 
AS 3 1.82% 
AS WITH AR 4 2.42% 
AR 2 1.21% 
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DISTRIBUTION OF CONGENITAL HEART DISEASES 
TABLE 11 
S.NO. TYPE OF HEART DISEASE NO. OF CASES 
PERCENTA
GE 
1 ASD 40 40.41% 
2 VSD 18 18.18% 
3 PDA 5 5.05% 
4 BICUSPID AORTIC VALVE/ AS 2 2.02% 
5 PS 3 3.03% 
6 TOF 4 4.04% 
7 EBSTEIN 1 1.01% 
8 ASD & MVPS/ VSD & MVPS 2 2.02% 
9 TR 9 9.09% 
10 TGA 2 2.02% 
11 WPW SYNDROME 2 2.02% 
12 
DEXTROCARDIA WITH SITUS 
INVERSUS 1 
1.01% 
 
 
13 COARCTATION OF AORTA 2 2.02% 
14 EISENMEMGER SYNDROME 1 1.01% 
15 LUTEMBACHER SYNDROME (ASD+MS) 
2 2.02% 
16 ELLIS-VAN CREVELD SYNDROME 
1 1.01% 
17 INTER ATRIAL SEPTAL ANEURYSM 
4 4.04% 
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DISTRIBUTION OF MITRAL VALVE PROLAPSE 
SYNDROME 
Distribution of Mitral valve prolapse syndrome and associated 
pathology is as follows: 
TYPE OF MVPS CASES PERCENTAGE 
NO 
FUNCTIONAL 
DERANGEMENT 
21 40.39% 
MVPS / MR 22 42.30% 
MVPS / TR 1 1.92% 
MVPS/ MR/ TR 4 7.69% 
MVPS / PR 2 3.85% 
MVPS/ AR 2 3.85% 
TOTAL 52 100% 
 
DISTRIBUTION ACCORDING TO NYHA STATUS 
The functional class of the patients according to the NYHA 
classification is shown in the following table. The classification of the 
functional status is done at the first time of presentation in our 
institution. 
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TABLE 12 
FUNCTIONAL CLASS NO. OF CASES PERCENTAGE 
I 100 29.59% 
II 121 35.80% 
III 80 23.67% 
IV 37 10.94% 
TOTAL 338 100% 
 
PREGNANCY OUTCOME IN RARE HEART DISEASE 
We had 2 cases of WPW syndrome admitted for safe 
confinement. One patient was multigravida and delivered by outlet 
forceps and the other was G2A1 and delivered by emergencyLSCS. 
There was no maternal or perinatal morbidity or mortality in these 
patients. 
There were 8 cases of cardiomyopathy in the study group. 3 
cases of dilated cardiomyopathy, 1 hypertrophic non obstructive 
cardiomyopathy and 4 peripartum cardiomyopathy cases were in the 
group. In one case of dilated cardiomyopathy, there was IUD because 
of severe pre-eclampsia and the pregnancy was terminated. There was 
 43 
 
no maternal or foetal complication in hypertrophic cardiomyopathy. 
Out of the 4 cases of peripartum cardiomyopathy, there was one 
maternal death and there was no perinatal mortality. One case of 
dilated cardiomyopathy came for MTP in view of heart disease and 
the patient had also completed her family. 
We had 6 cases of primary pulmonary hypertension during the 
study period. All cases were booked elsewhere and where referred to 
IOG in II and III trimesters for further management. All the patients 
were diagnosed to have primary pulmonary hypertension only after 
conception. All were primigravida. One patient had twin pregnancy 
following infertility treatment and she was diagnosed to have 
pulmonary hypertension only in the29th week of pregnancy and was 
referred for further management.she developed PPROM in the 35th   
week and Emergency LSCS was done for fetal distress. Both the 
babies were admitted in neonatal care unit for respiratory distress and 
both of them survived. 
There were 3 maternal deaths in patients with pulmonary 
hypertension. 1 out of the 3 patients had associated cirrhosis of liver/ 
portal hypertension/ HELLP syndrome. The patient died undelivered 
and post-mortem caesarean section was done immediately but the 
fetus died in-utero. 2 other patients delivered preterm babies and died 
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in the immediate postpartum period. One of them delivered a 2.1 kg 
baby and died on the 1st postnatal day and the other delivered a 0.7 kg 
fetus and died after 5 hrs. The fetus also expired immediately. Thus 
primary pulmonary hypertension had 50% mortality in our institute. 
There were 2 fetaldeath. One was an extreme preterm and other was 
preterm IUD following maternal death. No other morbidity or 
mortality was there in these patients. 
One case of sick sinus syndrome with permanent pacemaker 
delivered without any morbidity or mortality. One case of constrictive 
pericarditis with oesophageal varices who was admitted for safe 
confinement had a massive hematemesis at 29 weeks of gestation and 
developed hemorrhagic shock and ultimately death. This patient died 
undelivered. 
There were 2 cases of 1st degree heart block and 2 cases of 2nd 
degree heart block. One patient had hypothyroidism and one had 
gestational hypertension and gestational diabetes mellitus. These 
patients had no maternal or perinatal mortality during pregnancy and 
delivery. One patient with 3rd degree heart block on pace maker came 
for MTP and TAT was done in this patient along with MTP. 
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COMPLICATIONS OF HEART DISEASE 
This table depicts the various complications that developed in 
pregnant patients with heart disease. 19 patients developed congestive 
cardiac failure, 5 patients had acute pulmonary edema, 4 patients 
developed atrial fibrillation, 1 patient had embolic manifestation, 2 
patients had permanent pacemaker, 2 patients developed 
supraventricular tachycardia, 1 patient had severe Right ventricular 
obstruction. 
 
TABLE 13 
S. 
NO. 
COMPLICATION NO.OF 
CASES 
PERCENTAGE 
1. HEART FAILURE 19 54.28% 
2. ACUTE PULMONARY 
EDEMA 5 14.29% 
3. CCF/ ATRIAL 
FIBRILLATION 5 14.29% 
4. EMBOLIC 
MANIFESTATION 1 2.86% 
5. PERMANENT 
PACEMAKER 2 5.71% 
6. SUPRAVENTRICULAR 
TACHYCARDIA 2 5.71% 
7. SEVERE RV OUTLET 
OBSTRUCTION 1 2.86% 
8. TOTAL 35 100% 
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CO-EXISTENT MEDICAL DISORDERS OR OTHER 
PREGNANCY RELATED COMPLICATIONS 
The table below shows the various pregnancy related 
complications. 6 patients had anemia, 7 had gestational hypertension, 
3 patients had pre-eclampsia, 3 patients had gestational diabetes, 
bronchial asthma, 3 patients were Rh- Negative, 1 case had previous 
history of cerebro vascular accident, 3 patients had lower respiratory 
tract infection, 2 patients were deaf & mute, 3 patients had 
hypothyroid, 1 case was hyperthyroid, 1 patient had epilepsy, 1 had 
fever,1 was H1N1  positive, 1 was HBSAg positive, 1 had chicken pox 
with viral myocarditis, 1 had urinary tract infection, 1 had 
oesophageal varices. 
Few patients had more than one complication. GDM with GHT 
was seen in 2 patients, 1 pre-eclampsia patient developed grade II 
abruption, 1 patient had GHT with hypothyroidism, 1 had cirrhosis of 
liver/ portal hypertension with HELLP syndrome, 1 had fever with 
LRI. 
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TABLE 14 
S.NO. COMPLICATIONS NO.OF CASES 
PERCENTA
GE 
1 ANEMIA 6 11.77% 
2 GHT 7 13.74% 
3 GDM 3 5.88% 
4 PRE-ECLAMPSIA 3 5.88% 
5 Rh- NEGATIVE 8 15.69% 
6 LRI 3 5.88% 
7 HYPOTHYROID 3 5.88% 
8 DEAF & MUTE 2 3.92% 
9 BRONCHIAL ASTHMA 1 1.96% 
10 EPILEPSY 1 1.96% 
11 CVA 1 1.96% 
12 HYPERTHYROID 1 1.96% 
13 FEVER 1 1.96% 
14 UTI 1 1.96% 
15 H1N1 POSITIVE 1 1.96% 
16 HBSAg POSITIVE 1 1.96% 
17 CHICKEN POX 1 1.96% 
18 OESOPHAGEAL VARICES 1 1.96% 
19 GDM & GHT 2 3.92% 
20 GHT& HYPOTHYROID 1 1.96% 
21 GHT & ABRUPTION 1 1.96% 
22 FEVER & LRI 
1 1.96% 
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23 CIRRHOSIS OF LIVER/ PORTAL 
HYPERTENSION WITH HELLP 
SYNDROME 1 1.96% 
24 TOTAL 
51 100% 
 
DISTRIBUTION OF SURGICALLY CORRECTED HEART 
DISEASES 
This table shows various surgical treatment which the patients 
underwent for the correction of heart disease. 13 patients underwent 
closed mitral valve commissurotomy (CMC), 1 underwent balloon 
valvoplasty, ASD closure was done in 18 patients, VSD closure was 
done in 5 patients, PDA ligation was done in 2 patients, both ASD and 
VSD closure was done in 2 patients, mitral valve replacement was 
done in 9 patients, VSD closure with aortic valve replacement was 
done in 1 patient, 2 patients had permanent pacemakers.  
Among the patients with Rheumatic heart disease, mitral valve 
surgery was the commonest procedure done. CMC was the 
commonest among the procedures followed by MVR. One patient 
who underwent CMC had atrial fibrillation before surgery. One 
patient underwent CMC during term gestation as she had severe mitral 
stenosis with repeated attacks of acute pulmonary edema. 
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TABLE 15 
S.NO. SURGERY 
NO.OF 
CASES 
PERCEN
TAGE 
1. Closed Mitral Valve 
Commissurotomy 
14 25% 
2. Balloon valvoplasty 1 1.78% 
3. ASD closure 18 32.15% 
4. VSD closure 5 8.93% 
5. PDA ligation 2 3.57% 
6. Mitral valve replacement 9 16.08% 
 
7. ASD & VSD closure 2 3.57% 
8. VSD closure with Aortic 
valve replacement 
1 1.78% 
9. Pace maker 2 3.57% 
10. TGA CORRECTED 2 3.57% 
11. TOTAL 54 100% 
 
  Patient was hemodynamically stable during and after the 
procedure and during labour and delivery. She underwent emergency 
LSCS for fetal distress. One patient who underwent MVR had atrial 
fibrillation before procedure. 
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Out of the 14 patients who underwent CMC, one patient 
underwent MTP as she had completed family and 3 patients 
underwent MTP as CMC was planned in these patients. 
Out of the 9 patients who underwent MVR, 3 patients 
underwent MTP and 2 of these patients underwent MTP as MVR was 
planned in these patients. 
Most of the patients who underwent mitral valve surgery, were 
in NYHA class I or II. Following the surgical correction,these patients 
less frequently required anti-failure treatment and the maternal and 
perinatal outcome was good in these patients. 
Surgical correction of congenital heart disease was the most 
common procedure in study group especially ASD closure was the 
commonest procedure among the study group. One patient had UTI, 
one had hypothyroidism. 
Of the patients with corrected TGA, 1 delivered a preterm baby 
which died after 5 days due to respiratory distress. Manual removal of 
placenta was done in the same patient. 
VSD closure was done in 5 patients. There was no complication 
among these patients during pregnancy. 
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One patient sick sinus syndrome had permanent pacemaker and 
it was before pregnancy. She had no complication during pregnancy, 
labour and delivery. 
The maternal and foetal outcome was favourable in all the surgically 
treated patients. Except for one preterm death, there was no other 
maternal or foetal death. All these patients were hemodynamically 
stable during pregnancy, labour, delivery and puerperium. 
 
DISTRIBUTION OF CASES ACCORDING TO THE PURPOSE 
OF ADMISSION 
TABLE 16 
S.NO. 
PURPOSE OF 
ADMISSION 
NO. OF 
CASES 
PERCENTAGE 
1. SAFE CONFINEMENT 302 89.35% 
2 MTP 36 10.65% 
3 TOTAL 338 100% 
 
Among the heart disease patients under study, 302 were admitted for 
safe confinement and 36 patients were admitted for MTP. 
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PREGNANCY OUTCOME IN PATIENTS ADMITTED FOR 
SAFE CONFINEMENT 
TABLE 17 
PREGNANCY OUTCOME NO.OF CASES PERCENTAGE 
VAGINAL DELIVERY 182 60.27% 
CAESARIAN SECTION 119 39.40% 
DIED UNDELIVERED 1 0.33% 
TOTAL 302 100% 
 
Among the 302 patients, 182 patients delivered by vaginal route 
and 119 patients delivered by caesarean section and one patient died 
undelivered. 
DISTRIBUTION OF VAGINAL DELIVERY 
This table shows split up of deliveries that occurred by vaginal 
route. 50 patients had normal vaginal delivery. 120 delivered by outlet 
forceps with episiotomy, 7 patients had vacuum extraction with 
episiotomy,1 case of assisted breech delivery,  2 cases of VBAC- out 
of which one was a normal vaginal delivery and the other was an 
assisted breech delivery, and 2 spontaneous expulsion of dead foetus 
with placenta and membranes in toto. 
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TABLE 18 
S.NO TYPE OF DELIVERY NO. OF CASES PERCENTAGE 
1 LABOUR NATURALIS 
50 27.27% 
2 OUTLET FORCEPS 
DELIVERY 120 66.37% 
3 VACUUM 
EXTRACTION 7 3.64% 
4 ASSISSTED BREECH 
DELIVERY 1 0.54% 
5 VBAC 
2 1.09% 
6 SPONTANEOUS 
EXPULSION OF DEAD 
FETUS 
2 1.09% 
6 TOTAL 
182 100% 
 
DISTRIBUTION OF LABOUR NATURALIS 
TABLE 19 
S.NO. TYPE OF DELIVERY 
NO. OF 
CASES 
PERCENTAGE 
1 LABOUR NATURALIS 5 10% 
2 LABOUR NATURALIS / 
LACERATED PERINEUM 
6 12% 
3 LABOUR NATURALIS/ 
EPISIOTOMY 
39 78% 
4 TOTAL 50 100% 
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DISTRIBUTION OF CAESAREAN SECTION 
Out of the 119 caesarean section done, the following table 
shows the distribution of cases.  All caesarean sections were done for 
obstetric indication out of which 92 were Emergency caesarean 
sections and 27 were Elective caesarean sections. 
TABLE 20 
CAESAREAN 
SECTION 
TYPE CASES PERCENTAGE 
EMERGENCY 
CAESAREAN 
PRIMARY 72 60.50% 
REPEAT 20 16.81% 
ELECTIVE 
CAESAREAN 
PRIMARY 4 3.36% 
REPEAT 23 19.33% 
TOTAL - 119 100% 
 
63.86% were primary section and 36.14% were repeat caesarean 
section. 
INDICATIONS FOR CAESAREAN SECTION 
PRIMARY ELECTIVE CAESAREAN SECTION 
Indications for primary elective caesarean section are shown in the 
diagram5.
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DIAGRAM 6: INDICATIONS FOR EMERGENCY 
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DIAGRAM 7: INDICATIONS FOR ELECTIVE REPEAT 
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EMERGENCY PRIMARY CAESAREAN SECTION 
Indications for emergency primary caesarean section are shown 
in the diagram 6. 
2 of the caesarean section done for foetal distress were twins 
ELECTIVE REPEAT CAESAREAN SECTION 
Indications for elective repeat caesarean section are shown in 
the diagram 7. 
EMERGENCY REPEAT CAESAREAN SECTION 
Indications for emergency repeat caesarean sections are shown 
in the diagram 8. 
Out of the 2 caesarean done for breech one was a twin 
pregnancy with 1st twin in breech presentation. Out of the CPD cases 
in labour, one case was a grade II abruption with IUD. 
DISTRIBUTION OF BIRTH WEIGHT 
The following table shows the distribution of birth weight of the 
babies delivered. 304 babies were delivered by the 301 patients with 
heart disease, of which 3 were twin deliveries. Birth weight of 13 
babies were ≤1.5 kilo, weight of 20 babies were between 1.51 – 2 
kilos, 89 babies were between 2.01 – 2.5 kilos, weight  of 125 babies 
was between 2.51 – 3 kilos, 49 babies were between 3.01 – 3.5 kilos 
and 8 babies were above 3.51 kilos. 
 56 
 
TABLE 21 
BIRTH WEIGHT (in Kg) CASES PERCENTAGE 
≤ 1.5 13 4.27% 
1.51- 2 20 6.58% 
2.01 – 2.5 89 29.28% 
2.51 – 3 125 41.12% 
3.01 – 3.5 49 16.12% 
≥3.51 8 2.63% 
TOTAL 304 100% 
 
DISTRIBUTION ACCORDING TO MATURITY OF BABIES 
Out of the 304 babies delivered, 31 babies were preterm and 
273 babies were term babies. There was no evidence of congenital 
heart disease in the babies born to the mothers with congenital heart 
disease. Out of the 31 preterm babies 2 were extreme preterm and 
delivered as spontaneous expulsion with placenta and membranes in 
toto. 
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TABLE 22 
MATURITY NO. OF CASES PERCENTAGE 
TERM 274 90.13% 
PRETERM 30 9.87% 
TOTAL 304 100% 
 
DISTRIBUTION OF TWIN DELIVERIES 
3 set of twins were in the study group.  Babies born out of 2 
twin deliveries were preterm and one twin delivery was term. All 
deliveries were caesarean section. 2 were Emergency LSCS and 1 was 
Emergency repeat LSCS. One patient had primary pulmonary 
hypertension, and 2 patients had rheumatic mitral stenosis. 
All the four preterm twins required admission into the neonatal 
unit and there was no perinatal mortality among the twin babies. 2 of 
the patients with twin pregnancies had NYHA status II and one 
patient’s NYHA status was class IV. There was no maternal mortality 
among the patients with twin pregnancy. 
  
 
 
 
DIAGRAM 9: DISTRIBUTION OF TWIN DELIVERIES
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DISTRIBUTION OF PERINATAL DEATH 
Reasons for perinatal mortality was respiratory distress 
syndrome in 3 preterm babies, prematurity in 3 babies, and severe 
IUGR and birth asphyxia in one term baby. Perinatal mortality is 2.3% 
in the study. 
DISTRIBUTION OF PERINATAL MORBIDITY 
Out of 297 live born babies, 26 babies required   admission into the 
neonatal intensive care unit. 16 admissions were due to respiratory 
distress, 2 were due to IUGR, 1 was due to meconium aspiration, 3 
admissions were due to SGA, 4 admissions were for neonatal care as 
the mothers had cardiac complications. 
TABLE 23 
PURPOSE OF ADMISSION NO. OF CASES NO. OF DEATHS 
RDS 16 3 
IUGR 2 - 
MECONIUM ASPIRATION 1 - 
SGA 3 - 
MATERNAL 
COMPLICATION 
4 - 
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Out of the 26 admissions, 3 babies expired in the early neonatal 
period due to respiratory distress syndrome. 
 
CONTRACEPTION 
The following table shows the different methods of 
contraception- both temporary and permanent among the 338 patients 
included in the study. 
Some method of contraception was used in 304 patients either 
temporary or permanent. No contraception was used in 34 patients due 
to some maternal or fetal complication. 
The distribution is as follows: 
169 Copper-T insertions were done which included both post-
placental and interval copper- T insertions, 59 patients underwent 
puerperal sterilisation,46 had concurrent sterilisation with caesarean 
section, 30 patients had concurrent sterilisation with MTP.Out of the 
169 copper –T insertions, 163 were following deliveries and 6 were 
following MTP. 
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TABLE 24 
CONTRACEPTION NO. OF CASES PERCENTAGE 
COPPER-T 169 55.6% 
PUERPERAL 
STERILISATION 
59 19.41% 
LSCS with STERILISATION 
46 15.13% 
MTP with STERILISATION 
30 9.86% 
TOTAL 304 100% 
 
DISTRIBUTION OF PERMANENT METHODS OF 
CONTRACEPTION 
TABLE 25 
METHODS NO. OF CASES PERCENTAGE 
PUERPERAL 
STERILISATION 
59 43.7% 
LSCS with 
STERILISATION 
46 34.08% 
MTP with 
STERILISATION 
30 22.22% 
 
TOTAL 135 100% 
 
59 patients underwent puerperal sterilisation following vaginal 
deliveries. 46 patients underwent concurrent sterilisation with LSCS. 
 61 
 
Out of the 338 patients, 39.94% of the patients adopted a 
permanent method of sterilisation. 
 
DISTRIBUTION FO PATIENTS ADMITTED FOR MTP 
TABLE 26 
 
Only one MTP was done in the II trimester and 35 were done in the I 
trimester. 
DISTRIBUTION OF MTP ACCORDING TO THE SIZE OF 
THE FAMILY 
MTP was done in one primigravida because of Eisenmenger’s 
syndrome59. 15 patients had one live child and 20 patients had 
completed their family with 2 or more live children. 
 
TRIMESTER OF 
MTP 
NO. OF CASES PERCENTAGE 
I TRIMESTER 35 97.22% 
II TRIMESTER 
1 2.78% 
TOTAL 36 100% 
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TABLE 27 
 
 
DISTRIBUTION OF USE OF CONTRACEPTION 
FOLLOWING MTP 
TABLE 28 
S. NO. 
TYPE OF 
CONTRACEPTION 
NO. OF 
CASES 
PERCENTAGE 
1 COPPER- T 6 16.67% 
2 TUBECTOMY 30 83.33% 
4 TOTAL 36 100% 
 
Out of the 36 patients admitted for MTP, 14 patients underwent 
MTP as they had completed their family, 19 patients underwent MTP 
as it was indicated because their heart disease and 3 patients 
FAMILY SIZE NO. OF CASES PERCENTAGE 
NO LIVE CHILD 1 2.78% 
ONE LIVE CHILD 15 41.67% 
TWO OR MORE 
LIVE CHILDREN 
20 55.55% 
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underwent MTP as a cardiac corrective surgery had been planned and 
MTP was done as per cardiologist’s advice. As mentioned in the table, 
30 patients underwent tubectomy, 6 patients had copper-T insertion 
following MTP. All patients were stable during the procedure and 
after the procedure and discharged without any complication. 
All first trimester MTPs were done by manual vacuum 
aspiration using an MVA syringe. Second trimester MTP was done in 
only one patient because of her cardiac condition. 
ANALYSIS OF DEATH IN PREGNANT PATIENTS WITH 
HEART DISEASE 
There were 14 deaths among the total 338 patients studied. 
1patient died undelivered at 30 weeks of pregnancy. In one patient 
post-mortem caesarean was done but the baby also died in-utero. 
Cause of death was cardio respiratory arrest in 5 cases, 
pulmonary oedema in 6 cases, haemorrhagic shock in 2 cases, and 
pulmonary embolism in 1 patient.  
All cases had been booked elsewhere and they were referred to 
IOG for further management in a serious condition.Functional status 
of 11 patients was class IV at the time of admission and class II for 
one patient and class I for one patient. 
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2 patients had associated cirrhosis of liver with oesophageal 
varices, one patient had chicken pox complicated by viral myocarditis, 
one was H1N1 positive, 1 patient had pre- eclampsia as coexisting 
medical disorders.11 patients were diagnosed to have heart disease 
before pregnancy and one patient developed viral myocarditis and one 
developed peripartum cardiomyopathy.  
9 cases were on anti-failure drugs and despite treatment the 
condition deteriorated. In 2 cases there was massive variceal bleeding 
leading to acute decompensation because of hypovolemia. In one 
patient there was chicken pox in the last week of pregnancy and 
patient developed viral myocarditis and went into sudden cardio 
respiratory arrest on the day of delivery. 
One patient with critical mitral stenosis acquired H1N1 infection 
which proved to be fatal in her on the 7th post natal day. One patient 
died on 4th post natal day due to atrial fibrillation. All other patients 
developed decompensation in the immediate postpartum period and 
collapsed and they could not be revived. 
4 patients had severe to critical mitral stenosis, 3 had primary 
pulmonary hypertension, one had large perimembranous VSD, one 
had MVPA of anterior mitral valve leaflet, one had constrictive 
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pericarditis, one had ASD, one had peripartum cardiomyopathy, and 
one had viral myocarditis. 
No patient had undergone any surgical correction of heart 
disease before pregnancy.11 patients were less than 30 years and 2 
patients were above 30 years. There was IUD in 4 cases and 
subsequentperinatal mortality in 3 cases and 6 neonates survived after 
maternal death. 
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DISCUSSION 
INCIDENCE 
In our study, the incidence of heart disease among the pregnant 
patients presented to IOG was 1.41%. it is comparable  and is similar 
to the incidence reported by various other authors in their study. 
AUTHOR YEAR INCIDENCE 
MUDALIAR- MENON60 1972 0.97% 
CHIA61 1998 0.7% 
DeSWIET& FIDDLE62 1999 0.5% 
WILLIAMS63 2001 1% 
IOG STUDY 2011 1.41% 
 
SOCIO ECONOMIC STATUS 
The prognosis of the patient with heart disease is influenced by 
their socio economic status. 88.76% of the patients included in our 
study were class IV and V. Comorbid conditions like anemia, 
infection and heart failure is more in the low socio economic status 
and these in turn complicate the pregnancy affecting the maternal and 
fetal outcome in a significant manner.nafeesa and associates published 
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a report in 1985 stating that 92% in their study group belonged to class 
IV and V.About 65.8% of the study group patients were from 
overcrowded urban areas in and around Chennai. 35.2% patients are 
from the rural areas of Tamilnadu. 
ANTENATAL CARE: 
In the study group, 3.97% patients were unbooked and 96.03% 
were booked. Majority of the study (96.03%) was booked either in 
IOG or elsewhere. Most of the patients with class IV NYHA status 
were booked elsewhere and were referred to IOG at a late stage for 
institutional management. All the unbooked cases were multigravida 
and 4 of them were diagnosed to have heart disease only in this 
pregnancy. There was no maternal or perinatal mortality among the 
unbooked. 
22.78% of the heart disease patients in the study group were 
diagnosed to have heart disease only during this pregnancy and 
77.22% were diagnosed before this pregnancy. Patients with regular 
routine antenatal check-up generally had a good maternal and 
perinatal outcome. 
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AGE AND PARITY 
Mudaliar and Menon in their study stated that in patients with 
Rheumatic Heart Disease the cardiac condition worsens with time 
preferably due to the progressive nature of the organic lesion and 
rather than the increasing parity of the patient. 
Among the study group, 90.82% of the cardiac patients were 
below 30 years of age. Though there is a consensus that, the younger 
the age the better is the prognosis of the patient, it also depends on the 
functional status of the patient. 
In a report published by Dr.LalithaSubramaniam, 20.5% 
patients with heart disease were grand multigravida whereas in the 
present study, the grand multigravida accounted for 1.8% of the study 
group and this illustrates the betterment in the knowledge regarding 
the risk of pregnancy among the patients with heart disease and 
increase in the awareness about various sterilisation methods for 
limiting the family size. 
TYPE OF HEART DISEASE 
In the various studies conducted by Mudaliar and Menon (1972) 
Kamala Sidkar(1980), the incidence of rheumatic heart disease among 
 69 
 
the pregnant cardiac patients is 90 – 96%. The studies published in 
western countries by Tan and De Swiet in 1998 stated that the 
incidence of rheumatic heart disease is 12%. Chia in 1998 gave a 
report that the incidence of rheumatic heart disease is 61.6% and the 
incidence of congenital heart disease is 38.4% 
In our present study, 48.81% of the patients had heart disease of 
rheumatic origin. 29.29% patients had congenital heart disease. Mitral 
valve prolapse was diagnosed in 15.39%. 1.78% patients had primary 
pulmonary hypertension, 2.66% had cardiomyopathy. Sick sinus 
syndrome was diagnosed in one patient, heart block in 4 patients, and 
viral myocarditis in one case. 
RHEUMATIC HEART DISEASE 
According to Szekely and Snaith, the distribution is as follows: 
dominant mitral stenosis lesion is seen in 90%, mitral regurgitation in 
6.6%, aortic stenosis in 1% and aortic regurgitation is seen in 2.5%. 
In contrast to this report, in our study, among the rheumatic 
heart disease patients, isolated mitral stenosis is seen in 35.15%, 
isolated mitral regurgitation was seen in 19.39%, 1.21% patients had 
aortic regurgitation, aortic stenosis was seen in 1.82%, mitral stenosis 
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with regurgitation was seen in 17.59% and aortic stenosis with 
regurgitation in 2.42% and 22.42% had multivalvular lesions.  The 
diagnosis of these lesions is very important in management of these 
patients during labour and delivery. The use of intravenous fluids 
mitral stenosis has to be restricted whereas in case of aortic stenosis, 
patient is managed on the wet side. 
CONGENITAL HEART DISEASE 
The incidence of the congenital heart disease is comparable 
with the incidence of the congenital heart disease in the general 
population. In our study, 40.41% had atrial septal defect and all the 
defects were of the ostium secundum type. 18.18% patients had 
ventricular septal defect, 5.05% patients had patent ductus arteriosus, 
3.03% had pulmonic stenosis, 4.04% had tetralogy of fallot, 9.09% 
had tricuspid regurgitation and 4.04% had interatrialseptal aneurysm.  
Incidence of Wolff Parkinson White syndrome, corrected 
Transposition of Great Vessels, Coarctation of Aorta, Lutembacher 
Syndromebicuspid aortic valve with aortic stenosis was 2.02% each. 
There was one case each of ASD with MVPS, VSD with MVPS, 
Dextrocardia with situsinversus, Eisenmenger syndrome, and Ellis 
Van Creveld syndrome. 
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The maternal and perinatal outcome in these patients was 
influenced by the functional status of these patients according to the 
NYHA classification. The outcome was generally good in most of 
these patients especially in those who had undergone surgical 
correction of the defects before pregnancy. In one case of 
Eisenmenger syndrome, pregnancy was terminated at 11 weeks due to 
poor maternal outcome in these patients.  
A rare case of Ellis Van Creveld syndrome at 30 weeks of 
gestation was referred to our institute. The patient had polydactyly 
with single atrium with pulmonary hypertension. She was diagnosed 
to have the cardiac lesion only at 29 weeks of pregnancy. The patient 
was in cardiac failure at the time of admission and went into 
spontaneous labour and delivered a dead born male baby and she 
expired on the 1st postnatal day. 
In the patients with cyanotic heart disease, the prognosis is 
generally considered to be poor. All the cases of Tetralogy of Fallot 
were of acyanotic type. The inter atrial septal aneurysm was 
congenital in origin and is associated with atrial septal defect in 2 
patients, mitral valve prolapse in 1 patient and tricuspid valve prolapse 
in 1 patient. There was no thromboembolic event among these 
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patients. One case of Ebstein’s anomaly had a successful pregnancy 
outcome without any maternal or fetal complication. 
Only one maternal death was in the congenital heart disease 
group. It was a case of large perimembranous VSD with severe 
secondary pulmonary hypertension. The baby was preterm and 
expired in 48 hrs. There were 4 neonatal deaths. 3 were preterm 
infants out of which one was ≤1 kg, all deaths were due to respiratory 
distress. One was an IUD and the patient delivered vaginally. 
3 patients with ASD, 1 with VSD and severe pulmonary 
hypertension and 1 with PDA came for MTP. And there was no 
complication in these patients. In one patient with ASD Copper-T was 
inserted and all others adopted the permanent methods of sterilisation. 
MITRAL VALVE PROLAPSE 
Mitral valve prolapse syndrome is most often seen in relation to 
pregnancy as its frequency of occurrence is common in young women 
(15%). 
In the present study, 15.39% of the pregnant patients had mitral 
valve prolapse syndrome. In most of the cases, mitral valve prolapse 
was diagnosed during the routine cardiology workup done in the 
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antenatal patients and the patients were totally asymptomatic. 
Although it is an incidental finding, patients with this syndrome might 
develop complications like arrhythmias, subacute bacterial 
endocarditis or any thromboembolic complication. 
In our study, 40.39% of patients diagnosed to mitral valve 
prolapse had no functional derangement like regurgitation. 42.30% 
patients had mitral regurgitation, 1.92% had tricuspid regurgitation, 
7.69% patients had both Mitral and tricuspid regurgitation, 3.85% had 
pulmonary regurgitation, and 3.85% had aortic regurgitation. Mitral 
valve prolapse associated with regurgitant lesions has been found to 
be a significant risk factor for bacterial endocarditis. 
One patient with mitral valve prolapse syndrome along with 
severe pre-eclampsia/ PPROM/ IUD developed acute pulmonary 
edema and died on the 1st postnatal day due to pulmonary edema. 
This implicates that rather than MVPS, the comorbid conditions 
contribute to the morbidity and mortality. 
RARE CARDIAC DISEASES IN PREGNANCY 
We had 2 cases of WPW syndrome admitted for safe 
confinement. One patient was multigravida and delivered by outlet 
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forceps and the other was G2A1 and delivered by emergency LSCS. 
There was no maternal or perinatal morbidity or mortality in these 
patients. 
 There were 8 cases of cardiomyopathy in the study group. 3 
cases of dilated cardiomyopathy, 1 hypertrophic non obstructive 
cardiomyopathy and 4 peripartum cardiomyopathy cases were in the 
group. In one cse of dilated cardiomyopathy, there was IUD because 
of severe pre-eclampsia and the pregnancy was terminated. There was 
no maternal or fetal complication in hypertrophic cardiomyopathy.  
Out of the 4 cases of peripartum cardiomyopathy, there was one 
maternal death and there was no perinatal mortality. One case of 
dilated cardiomyopathy came for MTP in view of heart disease and 
the patient had also completed her family. 
We had 6 cases of primary pulmonary hypertension during the 
study period. All cases were booked elsewhere and where referred to 
IOG in II and III trimesters for further management. All the patients 
were diagnosed to have primary pulmonary hypertension only after 
conception. All were primigravida.  
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One patient had twin pregnancy following infertility treatment 
and she was diagnosed to have pulmonary hypertension only in 
the29th week of pregnancy and was referred for further 
management.she developed PPROM in the 35th   week and Emergency 
LSCS was done for fetal distress. Both the babies were admitted in 
neonatal care unit for respiratory distress and both of them survived. 
There were 3 maternal deaths in patients with pulmonary 
hypertension. 1 out of the 3 patients had associated cirrhosis of liver/ 
portal hypertension/ HELLP syndrome. The patient died undelivered 
and post-mortem caesarean section was done immediately but the 
fetus died in-utero. 2 other patients delivered preterm babies and died 
in the immediate postpartum period.  
One of them delivered a 2.1 kg baby and died on the 1st 
postnatal day and the other delivered a 0.7 kg fetus and died after 5 
hrs. The fetus also expired immediately. Thus primary pulmonary 
hypertension had 50% mortality in our institute. There were 2 fetal 
death. One was an extreme preterm and other was preterm IUD 
following maternal death. No other morbidity or mortality was there in 
these patients.
  
 
ANALYSIS OF RARE HEART DISEASES 
S.NO NAME AGE PARITY  SES HEART DISEASE TYPE NYHA STATUS OUTCOME OF PREGNANCY B.WT(in KG) MATURITY  COMPLICATIONS OF HD MATERNAL COMPLICATION FETAL COMPLICATION 
1 GOWRAMMAL 21 G2A1 IV WPW SYNDROME II EMER.LSCS- FETAL DISTRESS 3.3 T - - - 
2 PAPPUTHAI 25 G3P1L1A1 V WPW SYNDROME II OUTLET FORCEPS 3 T - - - 
3 LAKSHMI 28 G3P1L1A1 IV PERIPARTUM CARDIOMYOPATHY IV LABOUR NATURALE  2.5 T CCF - - 
4 RADHADEVI 30 PRIMI IV PERIPARTUM CARDIOMYOPATHY IV EMER.LSCS-FETAL DISTRESS 2.7 T CCF DEATH - 
5 DEEPA 27 G2P1L1 V PERIPARTUM CARDIOMYOPATHY IV ELECTIVE RPT LSCS- PREV.LSCS/ CPD 3.5 T CCF - - 
6 LATHA 25 G2P1L1 V PERIPARTUM CARDIOMYOPATHY IV ELECTIVE RPT LSCS- PREV.LSCS/ CPD  3.75 T CCF - - 
7 CHITHRA 23 G2P1L1 IV DILATED CARDIOMYOPATHY III OUTLET FORCEPS 2.4 T - - - 
8 UMASHREE 20 G2A1 IV DILATED CARDIOMYOPATHY III OUTLET FORCEPS 2.5 T - GDM - 
9 KAVITHA  24 PRIMI IV DILATED CARDIOMYOPATHY IV SPONTANEOUS EXPULSION 0.9 PT CCF PRE ECLAMPSIA/ BRONCHIAL ASTHMA IUD 
10 PAVUN 23 PRIMI V EBSTEIN'S ANOMALY III EMER.LSCS- FETAL DISTRESS 3 T - - RDS 
11 PAVITHRA 20 PRIMI V ELLIS VAN CREVELD SYNDROME IV LABOUR NATURALE  1 PT CCF DEATH IUD 
12 DHANALAKSHMI 25 G2P1L0 V HYPERTROPHIC NON  OBSTRUCTIVE CARDIOMYOPATHY III EMER.LSCS- TRANSVERSE LIE 3.25 T - - - 
13 REVATHI 22 PRIMI III PRIMARY PULMONARY HYPERTENSION III EMER.LSCS-FETAL DISTRESS 2.5 T - - - 
14 PAPPATHI 28 PRIMI V PRIMARY PULMONARY HYPERTENSION III OUTLET FORCEPS 2.75 T - - - 
15 DURGA 21 PRIMI IV PRIMARY PULMONARY HYPERTENSION IV SPONTANEOUS EXPULSION 0.7 PT CCF DEATH EXPIRED 
 
  
 
ANALYSIS OF RARE HEART DISEASES 
16 GEETHA 29 PRIMI III PRIMARY PULMONARY HYPERTENSION IV POSTMORTEM CAESAREAN 1.4 PT CCF CIRRHOSIS OF LIVER/ PORTAL HYPERTENSION/ HELLP SYNDROME/ DEATH IUD 
17 MENAKA 21 PRIMI V PRIMARY PULMONARY HYPERTENSION IV OUTLET FORCEPS 2.1 T CCF DEATH - 
18 NARAYANAMMA 25 PRIMI IV PRIMARY PULMONARY HYPERTENSION IV EMER.LSCS- TWINS/ FETAL DISTRESS 1.2,1.1 PT,PT CCF - RDS 
19 BHAVANI 24 G2P1L1 V SICK SINUS SYNDROME  III LABOUR NATURALE  2.6 T PERMANENT PACEMAKER - - 
20 KAVITHA  23 PRIMI V 1ST DEGREE HEART BLOCK I OUTLET FORCEPS 2.75 T - - - 
21 NAMBEESWARI 24 G3P2L2 V 2nd DEGREE HEART BLOCK II OUTLET FORCEPS 2.75 T - - - 
22 SARASWATHI 24 G2P1L1 IV 2nd DEGREE HEART BLOCK III OUTLET FORCEPS 2.6 T - GDM/GHT RDS 
23 NITHYA 23 PRIMI V acyanotic TETRALOGY OF FALLOT III LABOUR NATURALE  2.5 T - - - 
24 SHARMILA 23 PRIMI IV ACYANOTIC TETRALOGY OF FALLOT III OUTLET FORCEPS 2.2 T severe RV OUTLET OBSTRUCTION - - 
25 SANDHYA 19 PRIMI V acyanotic TETRALOGY OF FALLOT III OUTLET FORCEPS 2.5 T - - - 
26 VALARMATHI 23 PRIMI V acyanoticTETRALOGY OF FALLOT III OUTLET FORCEPS 2.5 T - - - 
27 SANGEETHA 28 PRIMI III COARCTATION OF AORTA III ELECTIVE LSCS-CPD MAJOR/ COARCTATION OF AORTA 2.9 T - - - 
28 PARAMESWARI 28 PRIMI IV COARCTATION OF AORTA III ELECTIVE LSCS- COARCTATION OF AORTA 2.25 T - - - 
29 NITHYA 21 PRIMI IV TGA CORRECTED II VACCUM EXTRACTION 2.9 T - - 
 
30 SANGEETHA 25 G2A1 IV TGA CORRECTED/ small VSD III LABOUR NATURALE 1.8 PT - PPROM/MANUAL REMOVAL OF PLACENTA - 
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One case of sick sinus syndrome with permanent pacemaker 
delivered without any morbidity or mortality. One case of constrictive 
pericarditis with oesophageal varices who was admitted for safe 
confinement had a massive hematemesis at 29 weeks of gestation and 
developed hemorrhagic shock and ultimately death. This patient died 
undelivered. There were 2 cases of 1st degree heart block and 2 cases 
of 2nd degree heart block. One patient had hypothyroidism and one 
had gestational hypertension and gestational diabetes mellitus. These 
patients had no maternal or perinatal mortality during pregnancy and 
delivery. One patient with 3rd degree heart block on pace maker came 
for MTP and TAT was done in this patient along with MTP. There 
were 4 cases of Tetralogy of Fallot with no maternal death.1 case of 
Ellis-van Creveld syndrome was referred at 30 wks of pregnancy and 
died due to acute pulmonary edema. 
COMPLICATIONS OF HEART DISEASE IN PREGNANCY 
  Among the patients who developed cardiac complications, 
rheumatic heart disease was the most common underlying heart 
disease. Various complications seen in the patients with heart disease 
were acute pulmonary edema, congestive cardiac failure, atrial  
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HEART DISEASE 
NO. OF 
CASES 
NO. OF 
DEATHS 
MORTALITY 
PERCENTAGE 
PERIPARTUM 
CARDIOMYOPATHY 
4 1 25% 
PRIMARY 
PULMONARY 
HYPERTENSION 
6 3 50% 
DILATED 
CARDIOMYOPATHY 
3 0 0% 
HYPERTROPHIC 
NONOBSTRUCTIVE 
CARDIOMYOPATHY 
1 0%  
EBSTEIN’S 
ANOMALY 
   
ELLIS-VAN 
CREVELD 
SYNDROME 
1 1 100% 
SICK SINUS 
SYNDROME 
1 0 0% 
WPW SYNDROME 2 0 0% 
HEART BLOCK 
4 0 
0% 
 
TGA CORRECTED 2 0 0% 
TETRALOGY OF 
FALLOT 
4 0 0% 
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COARCTATION OF 
AORTA 
2 0 0% 
fibrillation, supraventricular tachycardia, pulmonary embolism and 
severe right ventricular outlet obstruction. 
CARDIAC FAILURE 
In the study group, 37 patients were in class IV NYHA status 
and 19 patients (5.62%) had cardiac failure at the time of admission. 
12 out of 19 patients with failure improved with anti-failure measures 
and supportive care in the intensive care unit. These patients were 
managed with expert opinion from the cardiologists and 
anaesthesiologists. 
Development of decompensation in the heart disease patients 
depends on the functional status of the patient before pregnancy and 
the hemodynamic burden imposed on the diseased heart by pregnancy. 
ATRIAL FIBRILLATION 
Szekely and Snaith in 1989 reported that atrial fibrillation 
increases the risk of thromboembolism and heart failure.  Pulmonary 
edema can develop in pregnancy when atrial fibrillation occurs in 
patients with mitral stenosis leading to the increase in maternal and 
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perinatal morbidity and mortality. Atrial fibrillation was seen in 4 
pregnancies (1.18%)among the heart disease patients under study. The 
incidence of atrial fibrillation reported by Szekely and Snaith(1974) 
was 6.5%.All the 4 patients developed heart failure and among them 
expired. Others patients recovered from the acute episode and were 
started on rate control drugs along with anti-failure drugs. These 
patients were put on anticoagulants until they recovered from the acute 
episode to prevent the development of thromboembolism as per 
cardiologist advice. 
ACUTE PULMONARY EDEMA 
Most common heart disease which developed Pulmonaryedema 
as a complication was rheumatic mitral stenosis. In our study group, 5 
patients (1.47%) developed pulmonary edema. out of these 5 patients, 
3 patients had severe mitral stenosis, 1 had critical mitral stenosis and 
1 patient had mitral valve prolapse with preeclampsia. In one patient 
with severe mitral stenosis acute pulmonary edema was precipitated 
by H1N1 infection. 
Pulmonary edema has been the single most important cause of 
death in patients with heart disease. 4 out of 5 patients with pulmonary 
edema could not be revived and they succumbed to the disease. 
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The risk of developing pulmonary edema coincided with period 
of pregnancy in which there is increased volume expansion and 
increased hemodynamic overload on the heart. In one patient 
pulmonary edema occurred in 32 weeks, in 2 patients it occurred near 
term and in one patient it developed 6 days after delivery. All patients 
were connected to ventilator with anti-failure measures and inotropic 
agents as per cardiologist’s advice. 4 out of 5 patietns could not be 
revived and they expired. In cases of severe mitral stenosis, the 
patients were already on anti-failure drugs and despite these measures 
they developed pulmonary edema. This emphasises the importance of 
pre-conceptional counselling and early termination of pregnancy if 
required when the patient is diagnosed to have a heart disease with 
poor cardiac reserve, so that death can be prevented in these patients. 
SUPRAVENTRICULAR TACHYCARDIA 
Supraventricular tachycardia complicated 2 pregnancies with 
atrial septal defect. Both patients were at term. 1case developed the 
complication in the antenatal period and the other patient developed it 
12 hours after delivery. Inspite of the intensive treatment and the 
prompt use of drugs, one patient could not be saved. 
 
 81 
 
PULMONARY EMBOLISM 
One patient with a large perimembranous VSD developed 
pulmonary embolism on the 3rd postnatal day and expired. The baby 
was a preterm and died due to respiratory distress. 
SEVERE RIGHT VENTRICULAR OUTLET OBSTRUCTION 
One case of acyanotic tetralogy of fallot had severe right 
ventricular outlet obstruction. Fortunately patient did not develop any 
complication and was discharged in a stable condition. 
COMORBID CONDITIONS 
ANAEMIA 
In our study 1.77% patients had co-existing anaemia. 6 cases of 
the 338 patients had anaemia along with heart disease. 5 patients had 
moderate anaemia and 1 patient had severe anaemia. Improved 
antenatal care has decreased the incidence of anaemia in the study 
group. The patient with severe anaemia is an unbooked case.  Patients 
with anaemia in our study belonged to low socio-economic status. 
Anaemia was linked to various complications like preterm delivery, 
IUGR, heart failure etc. 2 patients had preterm delivery, 1 patient had 
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IUGR, and 3 developed heart failure. There was no maternal or 
perinatal mortality. 
GESTATIONAL HYPERTENSION AND PREECLAMPISA 
In our study, 10 patients with heart disease had gestational 
hypertension and 3 patients had pre-eclampsia. The association of pre-
eclampsia with heart disease had a poor perinatal outcome due to 
further compromise in blood flow. 
2 patients with pre-eclampsia had IUD and one patient with 
gestational hypertension developed grade –II abruption and IUD. 2 
more babies had respiratory distress but recovered. 
RESPIRATORY COMPLICATIONS 
4 patients had lower respiratory infection and one had bronchial 
asthma. 3 patients developed heart failure but there was no maternal 
death in these patients. There was one IUGR delivery and 3 preterm 
deliveries among these patients out of which 2 expired.  There was 
one intrauterine death in the patient with bronchial asthma and pre-
eclampsia. One patient had fever with LRI and went into labour at 32 
weeks. The baby died due to respiratory distress and sepsis. 
Cardiorespiratory disorder in a heart disease patient further reduced 
the cardiopulmonary reserve and fetal complications are more due to 
increased hypoxic stress. 
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OTHER CONDITIONS 
6 patients had gestational diabetes, 6 patients had 
hypothyroidism, 1 had hyperthyroidism, 1 had epilepsy and 1 had 
previous history of cerebrovascular accident. 1 case had 
polyhydramnios, 1 was hepatitis B surface antigen positive, 1 had 
placenta praevia, 2 had oesophageal varices, 2 had PPROM and 8 had 
PROM and 1 had UTI. 
INFECTIVE ENDOCARDITIS 
2 patients in the study group had fever but no case of infective 
endocarditis was noted in our study group. All patients received 
antibiotics during parturition and infective endocarditis prophylaxis 
was given for all patients with valvular lesions with more pressure 
gradient across the valves. 
SURGICALLY CORRECTED CONGENITAL HEART 
DISEASE 
18 patients had undergone ASD closure in the childhood and 
adolescence period. 4 patients with VSD had undergone closure and in 
4 patients PDA ligation was done and TGA was corrected in 2 
patients. All these patients had a favourable pregnancy outcome and 
they were hemodynamically stable during pregnancy, labour, delivery 
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and puerperium. One patient had a preterm IUD and she delivered 
vaginally. There was no maternal mortality in this study group. 
 
PURPOSE OF ADMISSION 
In our study, 89.34% patients with heart disease were admitted 
for safe confinement and 10.65% patients were admitted for medical 
termination of pregnancy. 
7 patients were admitted in the II trimester and 1 patient died 
undelivered. Out of the 7 patients 6 were in heart failure at the time of 
admission. 
2 out of these 6 patients in failure had IUD. One patient was 
admitted for pre-eclampsia/ bronchial asthma/ IUD and the other had 
heart failure with IUD. 
1 out of the 6 patients in heart failure was an unbooked case/ 
previous LSCS and she was admitted for severe anaemia in labour and 
the patient delivered by assisted breech delivery.1 patient had 
constrictive pericarditis/ oesophageal varices with massive 
haemorrhage and the patient died undelivered at 29 weeks of 
pregnancy. 
1 out of the 7 patients admitted in second trimester was 
admitted for PPROM. 4 out of the 7 patients died. 
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MODE OF DELIVERY 
In the study group, among the 302 patients admitted for safe 
confinement 60.27% had vaginal delivery, 39.4% delivered by 
caesarean section and 1 patient died undelivered. Caesarean section 
was done for obstetric reasons and in 2 patients with coarctation of 
aorta; the heart disease per se was an indication for caesarean section. 
In a study published by Dr.K.Sidkar, 92% of the study group delivered 
vaginally and caesarean section was done in 1.7% and 3.5% patient 
died undelivered. 
In the present study the rate of caesarean sections done had 
increased but they were done mainly for obstetric indications. 63.86% 
were primary section and 36.14% were repeat caesarean section. 
In our study, 60.27% delivered vaginally and 66.37% were 
prophylactic outlet forceps delivery. 7 cases of vacuum extraction 1 
assisted breech delivery, 2 vaginal births after caesarean and 2 
spontaneous expulsion of dead fetus were under the study. Both the 
cases of VBAC got admitted at in the active phase of I stage of labour. 
One of them had a labour naturalis and the other had an assisted 
breech delivery. Copper – T was inserted in both of them as one baby 
was a preterm and the other was an IUGR baby. 
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TWIN PREGNANCY OUTCOME IN HEART DISEASE 
Twin pregnancy in heart disease predisposes the mother to 
greater risk of decompensation due to much higher hemodynamic 
overload in these patients. There were 3 twin pregnancies among the 
patients studied. 2 out of the 3 pregnancies delivered preterm and one 
delivered at term. All 3 underwent emergency caesarean section, 2 for 
fetal distress and for previous LSCS with 1st twin in breech 
presentation. The two sets of preterm babies were admitted in neonatal 
care unit due to respiratory distress. Weights of these babies were 
between 1.1kg and 2.6 kg. There was no maternal or perinatal 
mortality among these patients. This indicates that if the patient has 
good pre pregnancy cardiac reserve, the pregnancy will have a 
favourable maternal and perinatal outcome but the incidence of 
preterm labour is increased in the study group. 
FETAL OUTCOME 
Surgne and associates in 1981 proposed that the perinatal 
outcome in rheumatic heart disease in pregnancy is generally good 
and comparable to the patients without heart disease. 
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MATURITY AND BIRTH WEIGHT 
In our study 9.87% of the babies were preterm babies and 90.13% 
were term babies. 3 babies were SGA and 1 was an IUGR baby. 
35.86% of the babies had birth weight below 2.5 kg. 57.24% 
had birth weight between 2.51 – 3.5 kg and 2.63% babies were above 
3.51 kg. One baby was 4.1 kg. There were no congenital anomalies or 
congenital heart disease in the babies born to mothers with congenital 
heart disease. 
Incidence of congenital anomalies among babies born to mother 
with congenital heart disease in various studies is shown in the 
following table: 
AUTHOR YEAR INCIDENCE 
Whitemore et al 1982 10% 
Shime et al 1987 13% 
Perloff 1997 5-10% 
Our study 2001 Nil 
 
PERINATAL MORTALITY RATE 
There were 8 intra uterine deaths and 7 perinatal deaths out of 
the 304 babies delivered. Perinatal mortality was seen in 6 preterm 
babies and 1 term baby accounting for 2.3% of the babies in the study. 
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Perinatal mortality in various studies on heart disease 
complicating pregnancy is as follows: 
AUTHOR YEAR 
NO.OF 
CASES 
PERINATAL
MORTALITY 
Beebi et al 1985 500 13.6% 
Szekely and 
Snaith58 
1977 1000 35% 
DipakBabu et al 1995 74 5.4% 
Present study 2011 302 2.3% 
 
There is a decline in the perinatal mortality and morbidity with 
improvement in the antenatal care, prompt diagnosis and treatment of 
the comorbid conditions and treatment of infection if present, 
institutional delivery of the patients with heart disease and 
advancements in neonatal care. 
CONTRACEPTION 
According to Cheslay in 1978, the severity of rheumatic heart 
disease increases with age as there is progressive endomyocardial 
changes in the diseased heart. Hence the patients with rheumatic heart 
disease are generally advised to complete their family at a younger age 
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with an inter pregnancy interval of at least 1 to 2 years. This 
emphasises the counselling of the patient regarding the temporary and 
permanent methods of contraception. The use of improper 
contraceptive can be even life threatening in heart disease patients 
according to Brenner in 1975. Somerville in 1998 stated that patients 
with heart disease can be treated as any normal pregnant patient with 
regard to the use of contraceptive. 
In our study out of the total 338 patients, 304 patients adopted 
some form of contraception. Out of the 304 patients, 44.4%patients 
had undergone permanent sterilisation. All the patients had at least one 
live child. 
Out of the 44.4% patients, 19.41% underwent puerperal 
sterilisation, 15.13% patients underwent concurrent sterilisation with 
LSCS and 9.86% under tubectomy following MTP. 
 
MEDICAL TERMINATON OF PREGNANCY 
In 97.22% of cases, MTP was done in the I trimester by manual 
vacuum aspiration. 1 patient underwent II trimester MTP. II trimester 
MTP was performed using oral mifepristone and vaginal misoprostal 
without any complication. 
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Out of the 36 patients admitted for MTP, 14 patients underwent 
MTP as they had completed their family, 19 heart disease and 3 
patients underwent MTP as a cardiac corrective surgery had been 
planned and MTP was done as per cardiologist’s advice 
Copper- T was inserted in16.67% patients following MTP. And 
83.33% underwent tubectomy. 
All patients were stable during the procedure and after the 
procedure and discharged without any complication. 
MATERNAL MORTALITY 
According to the functional status of the patient the maternal 
mortality is as follows: 
STUDY 
NYHA CLASS I 
& II 
NYHA CLASS 
III & IV 
SULLIVAN (1985) 0.4% 4 -7% 
PRESENT STUDY 
(2011) 
0.29% 3.84% 
 
Maternal mortality in relation to heart disease in pregnancy has 
declined over the past 2 decades. Yet heart disease continues to be an 
important cause of maternal mortality in developing countries. Case 
fatality rate of heart disease in the present study is 4.1%. All but one 
patient were admitted with heart failure. 
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AUTHOR YEAR 
MATERNAL 
MORTALITY 
Koorin et al 1996 5.6% 
Jacob et al 1999 15% 
De Swiet 2000 3.8% 
Present study 2011 4.1% 
 
The statistics show that the heart disease still contributes 
significantly to the maternal mortality even in the most developed 
countries like United States. In the U.S. heart disease continues to be 
the cause for 10% of maternal death and this rate had remained 
relatively constant over the past 5 decades according to Eastby (1998). 
Case fatality rate of heart disease in pregnancy in the 
developing countries continues to be high ranging from 3 -6% mainly 
because of anaemia, lack of prenatal care and emergency admissions. 
 
 
 
  
 
ANALYSIS OF DEATH CASES 
S.No NAME AGE PARITY  
BOOKING  
STATUS HEART DISEASE TYPE 
PURPOSE OF 
ADMISSION 
NYHA 
STATUS 
OUTCOME OF 
PREGNANCY 
B.WT(in 
KG) MATURITY  
COMPLICATIONS OF 
HD 
MATERNAL 
COMPLICATION 
1 SARASWATHI 23 PRIMI B VIRAL MYOCARDITIS SC I 
LABOUR 
NATURALE  2.8 T CCF/ DEATH 
CHICKEN POX/ 
DEATH 
2 GEETHA 29 PRIMI B 
PRIMARY 
PULMONARY 
HYPERTENSION SC IV 
POSTMORTEM 
CAESAREAN 1.4 PT CCF 
CIRRHOSIS OF 
LIVER/ PORTAL 
HYPERTENSION/ 
HELLP 
SYNDROME/ 
DEATH 
3 RAJALAKSHMI 32 G2P1L0 B critical MS/ PHT SC IV 
ELECTIVE RPT 
LSCS-PREV LSCS/ 
CPD 2.3 T 
ACUTE PULMONARY 
EDEMA DEATH 
4 KALAIMAGAL 21 PRIMI B 
large 
perimembranous 
VSD/ severe PHT SC IV 
LABOUR 
NATURALE  1.5 PT 
PULMONARY 
EMBOLISM  DEATH 
5 MALAR 32 G3P2L2 B 
critical MS/ mild TR/ 
severe PHT SC IV OUTLET FORCEPS 1.25 T 
ATRIAL 
FIBRILLATION/ CCF DEATH 
6 RADHADEVI 30 PRIMI B 
PERIPARTUM 
CARDIOMYOPATHY SC IV 
EMER.LSCS-FETAL 
DISTRESS 2.7 T CCF DEATH 
7 DURGA 21 PRIMI B 
PRIMARY 
PULMONARY 
HYPERTENSION SC IV 
SPONTANEOUS 
EXPULSION 0.7 PT CCF DEATH 
  
 
 
ANALYSIS OF DEATH CASES 
 
8 USHA 24 G2P1L1 B ASD SC IV EMER.RPT.LSCS 
PREV.LSCS/CPD 
2.75 T SUPRAVENTRICULAR 
TACHYCARDIA 
DEATH 
9 MENAKA 21 PRIMI B PRIMARY 
PULMONARY 
HYPERTENSION 
SC IV OUTLET 
FORCEPS 
2.1 T CCF DEATH 
10 PAVITHRA 20 PRIMI B ELLIS VAN 
CREVELD 
SYNDROME 
SC IV LABOUR 
NATURALE 
1 PT CCF DEATH 
11 CHANDRIKA 23 PRIMI B Moderate to 
severe MS / 
severe PHT 
SC IV LABOUR 
NATURALE 
2.3 T ACUTE PULMONARY 
EDEMA 
GHT/DEATH 
12 POONGODI 22 PRIMI B Severe MS / 
moderate PHT 
SC IV OUTLET 
FORCEPS 
1.7 PT ACUTE PULMONARY 
EDEMA 
H1N1 POSITIVE /DEATH 
13 VIJAYA 20 PRIMI B CONSTRICTIVE 
PERICARDITIS 
SC IV UNDELIVERED - - CCF OESOPHAGEAL 
VARIES/HEMORRHAGIC 
SHOCK / DEATH 
14 PREETHI 20 G2A1 B MVPS of AML SC IV VACCUM 
EXTRACTION 
2.3 PT ACUTE PULMONARY 
EDEMA 
PRE ECLAMPSIA / 
PPROM/DEATH 
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SUMMARY 
• In the Institute of Obstetrics and Gynaecology, Egmore, 
Chennai during the study period from January 2011 to June 
2012.  
• 338 cases of heart disease complicating pregnancy were studied.  
• The incidence of heart disease in pregnant patients is 1.41%.  
• 64.8% from overcrowded areas of urban Chennai.  
• 35.2% of the patients came from a rural background.  
• 88.76% of the patients with heart disease belonged to class IV 
and V socioeconomic status.  
• 96.03% patients in the study group were booked cases.  
• 22.78% of the patients were diagnosed to have heart disease 
during pregnancy and 77.22% were diagnosed before 
pregnancy.  
• 90.82% of the patients were young and were less than 30 years 
of age.  
• Only 1.8% of the study group were grand multigravida.  
• 48.81% had rheumatic heart disease, 29.29% had congenital 
heart disease, 15.39% had mitral valve prolapse syndrome, 
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1.78% had primary pulmonary hypertension and 2.66% had 
cardiomyopathy.   
• Isolated cases of mitral stenosis contributed to 35.15% of the 
cases and mitral stenosis was seen in combination with other 
valvular lesions in 40.01% of the patients.  
• ASD is the most common congenital heart disease seen in the 
study group with an incidence of 40.41%.  
• 15.39% patients had MVPS in the study group.  
• 54 patients had undergone surgical treatment for heart disease.  
• 304 patients adopted some form of sterilisation out of which 
44.4% underwent permanent sterilisation. Copper – T was 
inserted in 55.6% of the patients.  
• The perinatal mortality in the study group was 2.3%. Maternal 
mortality was 4.1% in our study group. 
• Among the rare heart diseases,  
1. Primary Pulmonary Hypertension patients had 50% 
mortality. 
2. Peripartum cardiomyopathy had 25% mortality. 
3. Ellis-van Creveld syndrome had 100% mortality. 
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CONCLUSION 
Heart disease in pregnancy continues to be the majorcause of 
maternal mortality, preterm birth and perinatal mortality. Favourable 
outcome in pregnancies complicated by heart disease depends on the 
following factors: 
1. Age, socioeconomic status 
2. Functional capacity of the heart 
3. Early Booking and better antenatal care 
4. Comorbid conditions 
5. Quality of medical care 
Early termination of pregnancy and prompt use of permanent 
sterilisation methods improve the survival of women with high risk 
cardiac disease. 
Once the pregnant patient seeks medical care, risk stratification 
is achieved and pregnancy is continued in low risk group and the 
patients in high risk group are counselled for termination if necessary. 
Multidisciplinary approach with a team of obstetricians, 
cardiologist, anaesthetist, neonatologist combined with patient 
education provides the best opportunity to continue pregnancy with a 
good maternal and perinatal outcome. 
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In the future maternal mortality in heart disease patients can be 
brought down significantly by effective preconceptional counselling, 
and improvements in medical, surgical, antenatal, intranatal, and 
postnatal care and effective motivation for contraception. 
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First stage:   Posture                   : 
Pain relief methods : 
Duration  : 
Second stage:   Duration  : 
Prophylactic forceps 
/ vacuum : 
Third stage   :   Complications  : 
Management : 
4. Caesarean Section  : Elective/ Emergency 
Indication    : 
Type of Anaesthesia  : 
  
 
Complications    : 
Management    : 
5. Baby – Male/ Female  : 
Birth weight   : 
APGAR    : 
Preterm / Term / Postdated    : 
 
 
  
  
 
S.No
2 NAME 
AG
E IP NO.  PARITY  
SE
S 
BOOKIN
G  
STATUS HEART DISEASE TYPE 
PURPOSE 
OF 
ADMISSIO
N 
NYHA 
STATU
S 
OUTCOME OF 
PREGNANCY 
SEX 
OF 
BAB
Y 
B.WT(i
n KG) 
MATURIT
Y  
COMPLICATIONS 
OF HD 
MATERNAL 
COMPLICATION 
FETAL 
COMPLICATIO
N 
CONTRACEPTION
S  
1 KUMARI  23 192 PRIMI IV B MS/MR SC II OUTLET FORCEPS M 2.7 T - - - Cu-T 
2 SHOBANA 21 378 PRIMI IV B MVPS SC I 
EMER.LSCS -FAILED 
ACCELERATION M 3 T  - - - PS 
3 KAVITHA  20 891 PRIMI V B MVPS/MILD MR SC II OUTLET FORCEPS M 3.1 T - - 
 
Cu-T 
4 HEMALATHA 23 2043 G2P1L1 V B ASD SC I LABOUR NATURALE  F 2.75 T - - - Cu-T 
5 KAVITHA  23 2136 PRIMI V B 
1ST DEGREE HEART 
BLOCK SC I OUTLET FORCEPS M 2.75 T - - - Cu-T 
6 RAJATHI 22 33897 G2P1L0 III B MR/ trivial TR SC I 
EMER.LSCS-FETAL 
DISTRESS M 2.75 T - - - Cu-T 
7 MAHESWARI 23 3623 PRIMI IV B moderate MS SC II 
EMER.LSCS-FETAL 
DISTRESS M 3 T - - - Cu-T 
8 SUMATHI 20 3388 PRIMI IV B moderate MS SC II OUTLET FORCEPS M 2.5 T - - RDS Cu-T 
9 SHANTHI 29 3137 G2P1L1 V B 
moderate MS/severe 
MR SC II 
EMER.LSCS-FETAL 
DISTRESS M 2 T - - IUGR Cu-T 
10 BHAVANI 24 4413 G3P1L1A1 IV B 
severe MS/ moderate 
MR/ TR/ PHT SC III OUTLET FORCEPS M 2.7 T - - - PS 
11 RENUKA 20 4249 PRIMI V B MS/ MR/ TR/ PHT SC II OUTLET FORCEPS F 3.05 T - - - Cu-T 
12 MANIMEGALAI 26 4823 G3P2L1 IV B 
moderate MS/ mild 
MR/ TR/ AR/ mild PHT SC II OUTLET FORCEPS M 2.8 T - - 
 
PS 
13 SHANTHI 24 4454 G2P1L1 IV B PDA OPERATED SC I OUTLET FORCEPS F 2.75 T - - - PS 
14 NAMBEESWARI 24 3515 G3P2L2 V B 
2nd DEGREE HEART 
BLOCK SC II OUTLET FORCEPS M 2.75 T - - - PS 
15 INDRA 24 5137 G2P1L1 V B ASD CLOSURE DONE SC I LABOUR NATURALE  F 2.8 T - - - PS 
16 SEETHALAKSHMI 24 5243 G2P1L1 III B trivial MR SC I LABOUR NATURALE  M 2.25 T - - - PS 
17 JAYANTHI 24 5241 G2P1L1 IV B VSD SC II OUTLET FORCEPS F 2.6 T - - - PS 
18 KOMALAVALLI 29 5866 G2P1L1 IV B IAS ANEURYSM/ASD SC II LABOUR NATURALE  F 2.5 T - - - PS 
19 NITHYA 24 5829 G2P1L1 IV B 
MS/MR/PHT/MVR 
done SC II OUTLET FORCEPS M 2.4 T - - - PS 
20 YOGESWARI 20 6060 PRIMI V B mild TR SC I LABOUR NATURALE  M 3.15 T - - - Cu-T 
21 RAMA 26 6397 PRIMI V B 
mild MR/ moderate 
MS/ trivial TR/ 
moderate PHT  SC II OUTLET FORCEPS M 2.5 T - - - Cu-T 
22 GOVINDAMMAL 28 5947 G2P1L1 IV B ASD/ PHT SC II 
ELECTIVE RPT LSCS-
PREV LSCS/ BREECH M 2.95 T - - - LSCS-ST 
  
 
23 REVATHI 22 7048 PRIMI III B 
PRIMARY 
PULMONARY 
HYPERTENSION SC III 
EMER.LSCS-FETAL 
DISTRESS F 2.5 T - - - Cu-T 
24 ANJALI 21 6045 PRIMI IV B ASD CLOSURE DONE SC I OUTLET FORCEPS M 2.45 T - - - Cu-T 
25 LAKSHMI 28 6782 G2P1L1 IV B MS/MR/MVR done SC II VACCUM EXTRACTION M 2.6 T - - - PS 
26 NIRANJANA 23 7852 G2P1L1 V B MS/ MR SC II LABOUR NATURALE  F 2.5 T - - - PS 
27 NITHYA 21 6367 PRIMI IV B TGA CORRECTED SC II VACCUM EXTRACTION F 2.9 T - - - Cu-T 
28 DHANAKODI 21 7975 PRIMI IV B 
mild TR/ moderate 
PHT SC II OUTLET FORCEPS F 2.2 T - - SGA Cu-T 
29 PRIYA 23 6585 G2P1L0 V B 
severe MR/ MVR 
DONE SC II OUTLET FORCEPS M 2.8 T - - - Cu-T 
30 MANONMANI 25 8415 G2P1L1  V B ASD CLOSURE DONE SC II 
EMER RPT LSCS- PREV 
LSCS/ CPD F 2.5 T - - - LSCS-ST 
31 YOGESWARI 21 8756 PRIMI V B MR SC I OUTLET FORCEPS M 3.1 T - - - Cu-T 
32 PARAMESWARI 23 8798 PRIMI V B 
severe MS/ trivial AR/ 
moderate PHT SC III OUTLET FORCEPS F 2.3 T - - - Cu-T 
33 ANITHA 26 9311 G2A1 III B 
MVPS of AML/ trivial 
TR/ global hypokinesia SC III OUTLET FORCEPS F 2.75 T - - - Cu-T 
34 PRIYA 19 8666 PRIMI IV B 
mild MR/ moderate  
AR/ no PHT  SC III LABOUR NATURALE  F 3 T - - - Cu-T 
35 SATHYAVANI 20 8037 G2A1 IV B moderate MR SC II OUTLET FORCEPS M 2.7 T - - - Cu-T 
36 CHITHRA 29 8662 PRIMI IV B 
VSD  SPONTANEOUS 
CLOSURE SC I 
EMER.LSCS-FETAL 
DISTRESS F 2.75 T - - - Cu-T 
37 ABIRAMI 25 10755 G3P2L2 IV UB severe MS/ VPC SC III LABOUR NATURALE  F 2.6 T - - - PS 
38 LAKSHMI 28 10734 G2P1L1 V B moderate MS/ PHT SC II 
EMER.RPT.LSCS-PREV. 
LSCS/1ST TWIN BREECH M,M 1.5,1.4 PT,PT - - RDS Cu-T 
39 PAPPATHI 28 7967 PRIMI V B 
PRIMARY 
PULMONARY 
HYPERTENSION SC III OUTLET FORCEPS M 2.75 T - - - Cu-T 
40 KALPANA 24 8114 G2P1L1 V B MR SC I 
EMER.LSCS-FAILED 
INDUCTION M 2.5 T - - - LSCS-ST 
41 DEVI 27 8154 G4P2L1 V B severe MS/ mild MR SC II 
ELECTIVE RPT LSCS-
PREV LSCS/CPD F 2.6 T - - - LSCS-ST 
42 ILAKKIYA 19 9908 PRIMI V B 
moderate MS/ severe 
MR/ TR/ severe PHT SC III OUTLET FORCEPS F 2.6 T - - - Cu-T 
43 ESWARI  24 10974 PRIMI IV B 
MVP/ mild MR/ mild 
PHT SC II VACCUM EXTRACTION F 2.75 T - - - Cu-T 
44 NITHYA 23 11922 PRIMI V B 
acyanotic TETRALOGY 
OF FALLOT SC III LABOUR NATURALE  M 2.5 T - - - Cu-T 
45 REKHA 22 10450 G2P1L1 V B 
severe MR/ MVR 
DONE SC II 
EMER.LSCS-FETAL 
DISTRESS F 2.775 T - - - LSCS-ST 
46 REVATHI 24 11993 PRIMI V B ASD CLOSURE DONE SC I LABOUR NATURALE  F 2.3 T - - IUD Cu-T 
47 BHARATHI 28 11889 PRIMI IV B severe MR SC III OUTLET FORCEPS M 2.6 T - - - Cu-T 
  
 
48 LAKSHMI 28 12402 G3P1L1A1 IV B 
PERIPARTUM 
CARDIOMYOPATHY SC IV LABOUR NATURALE  F 2.5 T CCF - - Cu-T 
49 MENAKA 22 11787 G2A1 IV B severe AS/ severe AR SC III OUTLET FORCEPS F 1.7 PT - - - Cu-T 
50 VENDALAVANYA 23 12543 G2P1L1 V B severe MS/ mild PHT SC III 
EMER.RPT.LSCS-
PREVLSCS/CPD M 3.1 T - - - LSCS-ST 
51 NITHYA 27 12030 G2P1L1 IV B mild MR/ MVPS SC I 
EMER.RPT.LSCS-
PREVLSCS/CPD F 2.9 T - - - LSCS-ST 
52 NIRMALA 26 12505 G2P1L1 III B 
severe MS/ moderate 
PHT SC III 
ELECTIVE RPT LSCS-
PREV LSCS/CPD M 3.2 T - - - LSCS-ST 
53 PREMA 25 12862 G2A1 IV B 
severe MS/ moderate 
PHT/ CMC done SC III OUTLET FORCEPS M 2.75 T - - - Cu-T 
54 KRISHNAVENI 25 12834 PRIMI V B 
moderate MS/ 
moderate to severe 
AR SC III 
EMER.LSCS-CPD/FAILED 
ACCELERATION F 2.3 T - - - Cu-T 
55 KANNIYAMMAL 28 14321 PRIMI V B 
VSD CLOSURE/ 
AORTIC VALVE 
REPLACED SC II OUTLET FORCEPS M 2.55 T - - - Cu-T 
56 RAMYA 20 11779 PRIMI IV B mild MS/ trivial MR SC II OUTLET FORCEPS F 2.75 T - - - Cu-T 
57 PARAMESWARI 22 15028 G2P1L1 IV B 
severe MS/ severe 
PHT SC III LABOUR NATURALE  F 2.7 T - - - PS 
58 MOHANALAKSHMI 28 12599 PRIMI V B VSD SC I OUTLET FORCEPS F 2.6 T - - - Cu-T 
59 DHANALAKSHMI 21 15102 G2P1L1 V B trivial MR SC I OUTLET FORCEPS M 2.25 T - - - PS 
60 VASUKI 24 14962 
G3P1LOA
1 V B MS/ MR/ AR SC II OUTLET FORCEPS M 2 PT - - - - 
61 BRINDHA 25 14056 PRIMI IV B mild TR SC I 
EMER.LSCS-FAILED 
INDUCTION M 3.25 T - - - Cu-T 
62 PATCHAIAMMAL 29 10661 PRIMI IV B 
severe MR/ crirical 
MS/ moderate PHT SC IV 
EMER.LSCS-CPD/FAILED 
ACCELERATION M 2.5 T CCF - - Cu-T 
63 SRIDEVI 30 15026 PRIMI IV B ASD CLOSURE DONE SC I 
EMER.LSCS-FAILED 
INDUCTION F 2.25 T - - - Cu-T 
64 
SHANMUGALAKSH
MI 27 15562 G2P1L1 III B MS/ CMC DONE SC II 
EMER.RPT.LSCS- 
PREVLSCS/CPD F 2.4 T - - - LSCS-ST 
65 SAKIYA 24 
15793
1 G2P1L1 IV B trivial MR SC I 
ELECTIVE RPT LSCS-
PREV LSCS/ CPD M 3 T - - - LSCS-ST 
66 PARAMESWARI 20 16326 PRIMI IV B VSD SC I OUTLET FORCEPS F 2.5 T - - 
 
Cu-T 
67 SARANYA 22 13261 PRIMI V B mild MR SC I 
EMER LSCS-FETAL 
DISTRESS F 1.7 T - - IUGR Cu-T 
68 ESTHERKANI 25 17739 G3P2L1 V B MR/TR/ MVPS SC II OUTLET FORCEPS F 3.1 T - - - PS 
69 AMSA 28 17764 G3P1L1A1 IV B MS/ MR  SC II OUTLET FORCEPS M 2.25 T - - - PS 
70 LAKSHMI 23 17280 G2P1L1 IV B 
mild to moderate MR/ 
MVPS SC II 
ELECTIVE RPT LSCS-
PREVLSCS/CPD F 3.25 T - - - LSCS-ST 
71 RUKMANI 20 18049 PRIMI IV B moderate AS/ mild AR SC II 
EMER.LSCS-CPD/FAILED 
ACCELERATION M 2.6 T - - - Cu-T 
72 SULOCHANA 35 16723 G3P2L2 V UB MS/MR SC II LABOUR NATURALE  M 2.5 T - - - PS 
  
 
73 ABIRAMI 22 17970 PRIMI V B mild MR SC I LABOUR NATURALE  F 3 T - - IUD - 
74 RAMA 26 18370 PRIMI III B MS/ CMC DONE SC II OUTLET FORCEPS F 2 PT - - - Cu-T 
75 SATHYAVANI 22 18563 PRIMI IV B ASD/ PHT SC I 
EMER.LSCS-CPD/FAILED 
ACCELERATION M 2.75 T - - - Cu-T 
76 SEETHA 21 19161 PRIMI III B MVPS OF AML SC I 
EMER.LSCS-
PRIMI/BREECH M 1.75 PT - - - Cu-T 
77 JAYANTHI 25 16372 PRIMI IV B VSD SC I OUTLET FORCEPS M 2.7 T - - - Cu-T 
78 AMUL 23 20385 G2P1L1 V B VSD OPERATED SC I EMER.LSCS-BREECH  F 3.5 T - - - LSCS-ST 
79 KAVERI 23 20416 G2P1L1 V B ASD SC I LABOUR NATURALE  F 2.5 T - - - PS 
80 USHARANI 25 20393 PRIMI IV B ASD CLOSURE DONE SC I 
EMER.LSCS-SEVERE 
PREECLAMPSIA F 2.15 T - - - Cu-T 
81 JEEVA 36 20650 G5P1L1A3 V B MVPS/trivial mr SC I 
ELECTIVE RPT LSCS-
PREVLSCS/CPD M 2.75 T - - - LSCS-ST 
82 HEMALATHA 23 21252 PRIMI III B mild TR SC I VACCUM EXTRACTION M 3 T - - - Cu-T 
83 IRFANA 23 20420 G2P1L1 V B 
severe MS/ trivial MR/ 
moderate PHT SC III OUTLET FORCEPS F 2.5 T - - - PS 
84 CHITHRA 23 20745 G2P1L1 IV B 
DILATED 
CARDIOMYOPATHY SC III OUTLET FORCEPS F 2.4 T - - - PS 
85 SUGANYA 18 21560 PRIMI IV B mild MR/ mild TR SC II OUTLET FORCEPS F 2.4 T - - - Cu-T 
86 PRIYA 20 21295 PRIMI IV B 
critical MS/ moderate 
MR/ moderate PHT SC III OUTLET FORCEPS F 1.7 T - - SGA - 
87 ADHILAKSHMI 20 20740 G2P1L1 V B 
AS / CONGENITAL 
BICUSPID VALVE SC III LABOUR NATURALE  F 2.75 T - - - PS 
88 SIRIYAPUSHPAM 24 18798 PRIMI III B mild MS/ AR SC II OUTLET FORCEPS F 3 T - - - Cu-T 
89 KALAISELVI 28 22144 G2P1L1 V B 
severe MS/ mild MR/ 
PHT SC III 
ELECTIVE RPT LSCS- 
PREVLSCS/FLEXED 
BREECH M 2.9 T - - - LSCS-ST 
90 AMUDHA 26 22752 G2P1L1 IV B MS/ MVR SC II LABOUR NATURALE  F 1.8 T - - - PS 
91 KRISHNAVENI 25 22554 G2P1L1 V B mild MR/ mild TR SC I OUTLET FORCEPS M 2.5 T - - - PS 
92 NAGAMANI 19 23090 PRIMI IV B 
severe MS/ MR/ 
severe PHT SC IV OUTLET FORCEPS F 2.1 T CCF - - Cu-T 
93 POONGODI 27 23639 G4P2L2A1 V UB MVPS SC I OUTLET FORCEPS M 3.5 T - - - PS 
94 AMBIKA 22 23325 G3P1L1A1 IV B ASD SC I 
ELECTIVE RPT LSCS-
PREV.LSCS/CPD M 2.65 T - - - LSCS-ST 
95 LOGESWARI  18 23543 PRIMI III B ASD CLOSURE DONE SC I OUTLET FORCEPS F 2.7 T - - - Cu-T 
96 RAZIA 23 24029 PRIMI IV B IAS ANEURYSM/ MR SC II LABOUR NATURALE  F 2.75 T - - - Cu-T 
  
 
97 RENUKA 26 25348 G2P1L2 V B MVPS of AML SC I LABOUR NATURALE  F 3.15 T - - - PS 
98 PAVITHRA 18 25468 PRIMI V B 
ASD/ mild TR/ mild 
PHT SC II OUTLET FORCEPS F 2.5 T - - - Cu-T 
99 SHOBANA 23 25440 PRIMI III B MR/TR  SC II OUTLET FORCEPS F 2 T - - - Cu-T 
100 PADMA 30 25764 G3P1L1A1 V B PDA OPERATED SC I 
EMER.RPT LSCS-
PREV.LSCS/CPD M 2.75 T - - - LSCS-ST 
101 SHAMEEM 25 26505 G2P1L0 V B MS/ MR SC II 
EMER.RPT LSCS-
PREV.LSCS/THREATENE
D RUPTURE M 2.9 T - - - LSCS-ST 
102 SARIDHA BAI 21 26295 PRIMI V B ASD SC I OUTLET FORCEPS M 2.5 T - - - Cu-T 
103 KOKILA 27 27144 PRIMI IV B 
mild MR/ thickened 
aortic valve SC II OUTLET FORCEPS M 2.5 T - - - Cu-T 
104 JAYANTHI 25 27281 PRIMI IV B MVPS SC I OUTLET FORCEPS M 2.5 T - - - Cu-T 
105 VEDHA 25 19246 PRIMI IV B 
minimal MS/ 
moderate MR SC II 
EMER.LSCS-FETAL 
DISTRESS/TWINS M,F 2.6,2.1 T,T - - - Cu-T 
106 REVATHI 20 28764 G3A2 IV B VSD OPERATED SC I OUTLET FORCEPS F 2.5 T - - - Cu-T 
107 CHITHRA 26 28788 G5P2L2A2 IV UB mild MR/ TR SC I OUTLET FORCEPS F 3.1 T - - - PS 
108 YASODHA 28 28757 G2P1L1 IV B MVPS/ MR SC I LABOUR NATURALE  F 3.1 T - - - Cu-T 
109 MAHESWARI 32 28758 G2A1 V B MS/PHT SC II VACCUM EXTRACTION F 3.2 T - - - Cu-T 
110 REVATHI 23 28739 G2P1L0 V B 
severe MS/ moderate 
MR/ moderate AR/   
mild TR/ mild PHT SC III 
EMER.LSCS- FETAL 
DISTRESS F 2.5 T - - - Cu-T 
111 NAJIMUNISHA 35 31038 G3P1L1A1 V B ASD CLOSURE DONE SC I LABOUR NATURALE  M 2.25 PT - - - Cu-T 
112 SRIMATHI 19 31319 PRIMI V B 
mild to moderate MR/ 
MVPS SC I OUTLET FORCEPS M 3.2 T - - - Cu-T 
113 AMUDHA 25 30344 G2P1L1 III B MVPS/ MR SC I 
ELECTIVE RPT LSCS-
PREV.LSCS/CPD M 3.45 T - - - LSCS-ST 
114 VALARMATHI 23 31664 PRIMI V B 
acyanoticTETRALOGY 
OF FALLOT SC III OUTLET FORCEPS F 2.5 T - - - Cu-T 
115 ANITHA 24 31662 G2A1 IV B ASD CLOSURE DONE SC I 
EMER.LSCS-FETAL 
DISTRESS M 3.75 T - - - Cu-T 
116 SATHYA  24 31660 G2P1L0 IV B MS/ PHT SC II 
ELECTIVE RPT LSCS- 
PREVLSCS/ CPD F 3.45 T - - - Cu-T 
117 REKHA 22 29980 G3P2L1 IV B MS/ MR/ PHT SC II 
ELECTIVE RPT LSCS/ 
PREV.LSCS/ CPD F 2.9 T - - - LSCS-ST 
118 AMUL 25 33140 G2P1L1 III B severe MS/ MR/ TR  SC III OUTLET FORCEPS M 2.5 T - - - PS 
119 NASIMA 22 33289 G4P1L1A2 IV B MR SC I 
EMER.RPT.LSCCS-
PREV.LSCS/ CPD M 3.8 T - - - LSCS-ST 
  
 
120 VANITHA 25 12128 G2A1 IV B ASD CLOSURE DONE SC I 
EMER.LSCS-FETAL 
DISTRESS M 2.5 T - - - Cu-T 
121 VISALAM 26 32607 PRIMI V B MR/ PHT SC II 
EMER.LSCS-FETAL 
DISTRESS M 2.6 T - - - Cu-T 
122 VANI  37 33986 G3P1L1A1 V B AR/ MVPS SC I OUTLET FORCEPS M 2.75 T - - - Cu-T 
123 ZENATH 24 31787 PRIMI V B 
mild TR/ moderate 
PHT SC II OUTLET FORCEPS M 3 T - - - Cu-T 
124 KUMUDHA 20 33130 PRIMI V B MVPS SC I 
EMER.LSCS-FETAL 
DISTRESS M 3.1 T - - - Cu-T 
125 KALPANA 19 35953 PRIMI IV B VSD OPERATED SC I EMER.LSCS-CPD MAJOR M 3.8 T - - - Cu-T 
126 AMMU 27 36331 G2P1L1 V B AS/ AR SC II 
EMER.RPT.LSCS-
PREV.LSCS/ CPD F 2.8 T - - - LSCS-ST 
127 GOMATHI 28 36477 G3P2L2 IV UB severe MS SC IV OUTLET FORCEPS M 2.6 T 
ATRIAL 
FIBRILLATION/ CCF - - PS 
128 MANJULA 25 36623 G2P1L1 III B VSD OPERATED SC I 
ELECTIVE RPT LSCS-
PREV.LSCS/CPD M 2.8 T - - - LSCS-ST 
129 REVATHI 22 36745 G2P1L1 IV B mild TR SC I OUTLET FORCEPS M 2 T - - - PS 
130 BANU 21 36583 G2P1L1 IV B 
severe MS/ PHT/ CMC 
DONE SC III OUTLET FORCEPS M 2.6 T - - - PS 
131 GEETHA 25 34794 G2P1L1  V B 
severe MS/ moderate 
MR/ mild PHT SC III 
ELECTIVE RPT LSCS-
PREV.LSCS/BREECH F 3.45 T - - - LSCS-ST 
132 RANI 23 37175 PRIMI V B 
LUTEMBACHER 
SYNDROME(MS/ ASD) SC II 
EMER.LSCS-CPD/FAILED 
ACCELERATION M 3 T - - - Cu-T 
133 LIBIYAGLORY 23 37179 PRIMI V B VSD OPERATED SC I 
EMER.LSCS- FETAL 
DISTRESS F 2.8 T - - - Cu-T 
134 MAHESWARI 23 37700 PRIMI V B 
mild AR / mild MR/ 
CMC DONE SC II EMER.LSCS-CPD MAJOR  F  2.95 T - - - Cu-T 
135 DEVI 27 37715 PRIMI V B 
ISOLATED 
DEXTROCARDIA SC II 
EMER.LSCS- FETAL 
DISTRESS F 2.8 T - - - Cu-T 
136 KALAIVANI 29 38474 PRIMI IV B 
CONGENITAL 
BICUSPID AORTIC 
VALVE SC II 
EMER.LSCS- FETAL 
DISTRESS F 2.3 T - - - Cu-T 
137 BHAVANI 24 38547 G2P1L1 V B 
SICK SINUS 
SYNDROME  SC III LABOUR NATURALE  M 2.6 T 
PERMANENT 
PACEMAKER - - Cu-T 
138 GOWRAMMAL 21 38584 G2A1 IV B WPW SYNDROME SC II 
EMER.LSCS- FETAL 
DISTRESS M 3.3 T - - - Cu-T 
139 CHITHRA 35 38469 G3P2L2 III B moderate MR/ PHT SC II OUTLET FORCEPS M 2.5 T - - - Cu-T 
140 SEETHA 24 195 G3P1L1A1 V B mild MR/ mild TR SC I OUTLET FORCEPS F 2.75 T - - - PS 
141 SANGEETHA 28 37952 PRIMI III B 
COARCTATION OF 
AORTA SC III 
ELECTIVE LSCS-CPD 
MAJOR/ COARCTATION 
OF AORTA F 2.9 T - - - Cu-T 
  
 
142 DEEPA 27 38816 G2P1L1 V B 
PERIPARTUM 
CARDIOMYOPATHY SC IV 
ELECTIVE RPT LSCS- 
PREV.LSCS/ CPD M 3.5 T CCF - - LSCS-ST 
143 PANDIAMMAL 23 1047 PRIMI III B ASD CLOSURE DONE SC I 
EMER.LSCS- FETAL 
DISTRESS M 3.3 T - - - Cu-T 
144 KALA 21 1527 PRIMI IV B 
VSD/ SUBPULMONIC 
STENOSIS  SC II OUTLET FORCEPS M 2.4 T - - - Cu-T 
145 PARAMESWARI 28 1686 PRIMI IV B 
COARCTATION OF 
AORTA SC III 
ELECTIVE LSCS- 
COARCTATION OF 
AORTA F 2.25 T - - - Cu-T 
146 JAYACHITHRA 26 1111 G3P2L2 IV UB ASD/ MS/ MVR DONE SC III OUTLET FORCEPS F 1.85 PT - - RDS PS 
147 SHEELA 18 1241 PRIMI V B MR/ mild TR SC I OUTLET FORCEPS M 3 T - - - Cu-T 
148 JAYAPRADHA 22 2131 PRIMI V B 
MS/ PHT/ severe 
MVPS SC II OUTLET FORCEPS M 1.6 PT - - RDS - 
149 MEERA 20 2517 G2P1L1 IV B 
MVPS/ trivial TR/ 
trivial MR SC I 
EMER.RPT.LSCS- 
THREATENED RUPTURE F 2.5 T - - RDS PS 
150 ASHA 24 3036 G2P1L1 IV B MVPS/MR SC II OUTLET FORCEPS F 3.25 T - - - PS 
151 DEVI 24 3025 G2P1L1 IV B 
mild MS/ moderate 
MR SC II OUTLET FORCEPS F 3 T - - - PS 
152 MADHUBALA 20 2781 G2P1L1 V B mild MR SC I OUTLET FORCEPS F 2.6 T - - - PS 
153 ANEES NISHA 25 3294 G3P2L2 V B mild MR/ TR SC I EMER.LSCS- BREECH F 3.25 T - - - LSCS-ST 
154 MALLIGA 23 2408 G3P1L1A1 III B ASD SC I OUTLET FORCEPS F 2.6 T - - - Cu-T 
155 VALARMATHI 20 3290 PRIMI IV B moderate AS/ AR/ MR SC II 
EMER.LSCS- FETAL 
DISTRESS F 3.8 T - - - Cu-T 
156 SANGEETHA 27 4485 PRIMI V B trivial TR SC I 
EMER.LSCS - FETAL 
DISTRESS F 3.1 T - - - PS 
157 NISHA 20 4506 PRIMI IV B mild AS/ mild MR SC III 
EMER.LSCS- FETAL 
DISTRESS F 3.1 T - - - Cu-T 
158 SHARMILA 23 4677 PRIMI IV B 
ACYANOTIC 
TETRALOGY OF 
FALLOT SC III OUTLET FORCEPS F 2.2 T 
severe RV OUTLET 
OBSTRUCTION - - Cu-T 
159 LATHA 25 4315 G2P1L1 V B 
PERIPARTUM 
CARDIOMYOPATHY SC IV 
ELECTIVE RPT LSCS- 
PREV.LSCS/ CPD  F 3.75 T CCF - - LSCS-ST 
160 DHANALAKSHMI 25 4629 G2P1L0 V B 
HYPERTROPHIC NON  
OBSTRUCTIVE CARDIO 
MYOPATHY SC III 
EMER.LSCS- 
TRANSVERSE LIE M 3.25 T - - - Cu-T 
161 JOTHILAKSHMI 23 4526 PRIMI V B MVPS SC I VACCUM EXTRACTION M 2.4 PT - - - Cu-T 
162 SURYA 22 3410 PRIMI V B 
severe MS/ trivial TR/ 
moderate PHT SC III 
EMER.LSCS- CPD 
MAJOR M 2.75 T - - - Cu-T 
163 MANJU  21 5528 PRIMI III B 
mild MS moderate 
MR SC II 
EMER.LSCS- CPD/ 
FAILED ACCELERATION F 3.25 T - - - Cu-T 
164 SUMATHI 25 6027 PRIMI IV B 
perimembrnous VSD/ 
PULMONARY 
HYPERTENSION SC II 
EMER.LSCS- 
TRANSVERSE LIE M 2.9 T - - - Cu-T 
  
 
165 ASHA 22 6138 G2P1L1 IV B moderate MS/ MR SC II LABOUR NATURALE  M 2.3 T - - - PS 
166 REVATHI 21 6302 PRIMI III B ASD SC I 
EMER.LSCS- FETAL 
DISTRESS M 2.85 T - - - Cu-T 
167 PAVUN 23 6225 PRIMI V B EBSTEIN'S ANOMALY SC III 
EMER.LSCS- FETAL 
DISTRESS M 3 T - - RDS Cu-T 
168 SUBHA 21 6666 PRIMI IV B ASD CLOSURE DONE SC I 
EMER.LSCS- CPD/ 
FAILED ACCELERATION F 2.8 T - - - Cu-T 
169 SARALA 22 6635 G2P1L1 IV B mild AR SC II LABOUR NATURALE  M 2.8 T - - - PS 
170 DEEPA 21 6538 PRIMI IV B MVPS/ mild PR SC I 
EMER.LSCS- FETAL 
DISTRESS M 2.2 T - - - Cu-T 
171 GEETHA 25 6727 G2P1L0 V B mild MR SC I LABOUR NATURALE  M 2.25 T - - - Cu-T 
172 SATHYA 21 6264 G2P1L1 V B ASD SC IV LABOUR NATURALE  M 2.3 T 
SUPRAVENTRICULA
R TACHYCARDIA - - - 
173 ANNAPOORANI 24 6092 G2P1L1 IV B PDA NOT OPERATED SC II 
EMER.LSCS- FETAL 
DISTRESS F 3.25 T - - - LSCS-ST 
174 SANGEETHA 24 6599 G3P1L1A1 V B ASD CLOSURE DONE SC I 
EMER.RPT.LSCS- 
PREVLSCS/CPD M 3 T - - - LSCS-ST 
175 SATHYA 24 6602 G2P1L1 V B 
VSD SPONTANEOUS 
CLOSURE SC I OUTLET FORCEPS F 3.2 T - - - PS 
176 JUBETHA 20 7595 PRIMI V B MVPS OF AML SC I LABOUR NATURALE  F 1.7 PT - - RDS - 
177 SONA  24 7482 G2P1L1 IV B moderate MR SC II 
EMER.RPT.LSCS- 
PREVLSCS/CPD M 2.8 T - - - LSCS-ST 
178 SANDHYA 19 7887 PRIMI V B 
acyanotic TETRALOGY 
OF FALLOT SC III OUTLET FORCEPS F 2.5 T - - - Cu-T 
179 VALLIYAMMAL  25 8197 G2P1L1 III B 
moderate MS/ mild 
MR/ TR/ AR/ mild PHT SC III OUTLET FORCEPS F 2.5 T - - - PS 
180 PUSHPA 35 8356 G3P2L2 IV UB severe MS/ mild MR SC III OUTLET FORCEPS M 2.75 T - - - PS 
181 PRABAVATHI 28 8413 PRIMI III B MVPS SC I 
EMER.LSCS- CPD/ 
FAILED ACCELERATION F 4.1 T - - - Cu-T 
182 NATHIYA 21 7999 PRIMI V B severe MS/ mild PHT SC III OUTLET FORCEPS F 2.25 T - - - Cu-T 
183 NAGANANDHINI 29 7630 PRIMI V B mild AR/ TR SC II OUTLET FORCEPS F 3.4 T - - - Cu-T 
184 DHATCHAYANI 22 9600 PRIMI IV B moderate MS SC II OUTLET FORCEPS F 3 T - - - Cu-T 
185 ARCHANA 20 8689 PRIMI IV B MR / TR SC II OUTLET FORCEPS F 2.9 T - - - Cu-T 
186 MEGALA 26 9149 G3P2L2 V UB ASD CLOSURE DONE SC I OUTLET FORCEPS F 3.25 T - - - PS 
187 RAMA 27 10125 G2P1L1 V B 
severe MS/ mild MR/ 
moderate TR/ 
moderate PHT/ CMC 
DONE SC III OUTLET FORCEPS F 2.9 T - - - Cu-T 
  
 
188 VASUKI 32 5112 G3P1L1A1 III B 
moderate MS/ mild 
PHT/ CMC DONE SC III OUTLET FORCEPS F 3 T - - - PS 
189 LUBINAMARY 23 10472 G2P1L1 V B trivial MR SC I 
ELECTIVE RPT LSCS- 
PREV.LSCS/ CPD M 3.75 T - - - LSCS-ST 
190 UMA  24 11187 PRIMI IV B trivial TR SC I OUTLET FORCEPS F 2.6 T - - - Cu-T 
191 AMUDHA 20 11393 PRIMI IV B MVPS/ AR SC I OUTLET FORCEPS M 2.5 T - - - Cu-T 
192 VALARMATHI 25 11666 G2P1L1 IV B MS/ MR SC II OUTLET FORCEPS M 3 T - - - Cu-T 
193 SOWDAMANI 27 11793 G2P1L1 V B moderate MS SC II LABOUR NATURALE  F 3.2 T - - - PS 
194 PAPPUTHAI 25 12294 G3P1L1A1 V B WPW SYNDROME SC II OUTLET FORCEPS M 3 T - - - PS 
195 MUNIYAMMAL 39 12283 G8P5L5A2 V UB 
severe MS/ moderate 
PHT SC III OUTLET FORCEPS M 3.1 T - - - PS 
196 GAYATHRI 27 12712 PRIMI V B trivial MR / trivial TR SC I OUTLET FORCEPS F 2.8 T - - - Cu-T 
197 DHANABAKKIYAM 26 13855 G2P1L1 V B MR/ TR  SC II OUTLET FORCEPS F 2.7 T - - - PS 
198 SEETHA 21 13850 G2P1L1 V B 
severe MS/ MR/ AR/ 
TR/ mild PHT SC III OUTLET FORCEPS M 3.5 T - - - PS 
199 SELVI 22 13525 PRIMI V B 
moderate AS/ 
BICUSPID AORTIC 
VALVE SC II OUTLET FORCEPS M 2.9 T - - - Cu-T 
200 ANITHA 23 15270 PRIMI III B MVPS/PR SC I OUTLET FORCEPS F 2.5 T - - - Cu-T 
201 SUDHA 22 14735 PRIMI IV B mild MS SC II OUTLET FORCEPS F 2.7 T - - - Cu-T 
202 SIVARANJANI 23 15791 PRIMI IV B ASD/ TR SC I 
EMER.LSCS- FETAL 
DISTRESS M 2.9 T - - - Cu-T 
203 SATHYA 27 16002 PRIMI IV B moderate MS/ PHT SC II OUTLET FORCEPS F 2.5 T - - - Cu-T 
204 KANCHANADEVI 24 14598 G2P1L1 IV B mild MS/ trivial MR SC II 
ELECTIVE RPT LSCS- 
PREV.LSCS/ CPD F 2.7 T - - - LSCS-ST 
205 NARAYANAMMA 25 11573 PRIMI IV B 
PRIMARY 
PULMONARY 
HYPERTENSION SC IV 
EMER.LSCS- TWINS/ 
FETAL DISTRESS F,F 1.2,1.1 PT,PT CCF - RDS - 
206 MEGALA 23 16371 G3P1L1A1 IV B MS/ VPC SC III 
EMER.RPT.LSCS- 
PREV.LSCS/ CPD F 2.6 T - - - LSCS-ST 
207 DILLIRANI 28 15334 G2A1 V B mild MR SC I LABOUR NATURALE  F 2.75 T - - - Cu-T 
208 JAMEELA 22 15079 PRIMI V B 
PULMONARY 
STENOSIS SC II OUTLET FORCEPS M 2.6 T - - - Cu-T 
209 GUNASUNDARI 27 13956 G4P1L1A2 IV B MS/ MR CMC DONE SC IV OUTLET FORCEPS F 2.3 T 
ATRIAL 
FIBRILLATION/ CCF - - PS 
210 JAYASHREE 24 16683 G3P1L1A1 IV B MVPS OF AML SC I 
EMER.RPT.LSCS- 
PREV.LSCS/ SEVERE 
OLIGOHYDRAMNIOS M 2.75 T - - - LSCS-ST 
  
 
211 DHANALAKSHMI 25 15192 G3P2L1 V B trivial TR SC I LABOUR NATURALE  M 1.5 PT - - - Cu-T 
212 RAJANGAMMAL 27 18585 G2P1L1 IV B MVPS SC I OUTLET FORCEPS M 2.75 T - - - PS 
213 RADHA 23 14400 PRIMI III B mild MS SC I OUTLET FORCEPS M 2.3 T - - - Cu-T 
214 NITHYA 22 17228 PRIMI V B MS/ CMC DONE SC II OUTLET FORCEPS F 3 T - - - Cu-T 
215 SARALA 26 17138 PRIMI IV B ASD CLOSURE DONE SC I OUTLET FORCEPS F 2.75 T - - - Cu-T 
216 PRAVEENA 23 15945 G2A1 IV B IAS ANEURYSM/ TR SC II OUTLET FORCEPS F 2.6 T - - - Cu-T 
217 CHITHRA 21 17411 PRIMI IV B ASD/ VSD OPERATED SC II LABOUR NATURALE  F 2.4 T - - - Cu-T 
218 NITHYA 22 17384 PRIMI V B MS SC II 
EMER.LSCS- FETAL 
DISTRESS F 2.5 T - - - Cu-T 
219 NANDHINI 20 17675 PRIMI IV B MVPS/ trivial MR SC I OUTLET FORCEPS M 2.5 T - - - Cu-T 
220 ASHA 25 17767 PRIMI IV B MVPS/ MR SC II OUTLET FORCEPS M 2.6 T - - - Cu-T 
221 NAZEERABEGAM 23 18099 PRIMI V B MVPS SC I LABOUR NATURALE  F 2.5 T - - - Cu-T 
222 RUCKMANI 26 18149 G2P1L1 IV B VSD SC I 
VBAC/ LABOUR 
NATURALE M 2.1 T - - - Cu-T 
223 SHANMUGAPRIYA 23 18146 PRIMI IV B MVPS/ mild MR SC II 
EMER.LSCS- CDP/ 
FAILED ACCELERATION F 3.5 T - - - Cu-T 
224 MUNIYAMMAL 20 18700 G2A1 V B MVPS/ mild MR SC I 
EMER.LSCS- CORD 
PRESENTATION M 2.75 T - - - Cu-T 
225 JAYANTHI 23 18688 G2P1L1 IV B AS/ AR SC II OUTLET FORCEPS F 2.5 T - - - PS 
226 PAVITHRA 20 18231 PRIMI IV B severe MR/mild TR SC II OUTLET FORCEPS F 2.9 T - - - Cu-T 
227 SUSHEELA 29 18763 G4P2L2A1 III UB MVPS SC I LABOUR NATURALE  M 2.8 T - - - PS 
228 THENMOZHI 19 19005 PRIMI IV B severe MR SC III OUTLET FORCEPS M 2.5 T - - - Cu-T 
229 NIRMALA 19 18359 PRIMI V B severe AR/ MVPS SC III OUTLET FORCEPS F 2.25 T - - - Cu-T 
230 JOTHI  21 16351 PRIMI IV B 
severe MS/ severe 
PHT SC III OUTLET FORCEPS M 2.7 T - - - Cu-T 
231 DILLIRANI 27 19486 G2P1L1 IV B mild MR/ trivial TR SC II OUTLET FORCEPS F 2.2 T - - - PS 
232 SALOMI PRIYA 25 16771 PRIMI IV B mild AR SC II 
EMER.LSCS- CPD 
MAJOR M 3.1 T - - - Cu-T 
233 AMBIKA 22 2663 PRIMI IV B ASD SC III LABOUR NATURALE  M 2.15 PT - ANEMIA RDS - 
234 GOUSIYA 25 23098 G2P1L1 IV B severe MS/ TR/ PHT SC IV 
ELECTIVE RPT LSCS-
PREV.LSCS/CPD F 2.25 T CCF ANEMIA - LSCS-ST 
235 GOMATHI 22 37178 G2P1L1 V B MS/MR / AR SC IV 
ELECTIVE RPT LSCS- 
PREV.LSCS/ CPD M 2.8 T CCF ANEMIA - LSCS-ST 
  
 
236 RADHA  19 10356 PRIMI IV B trivial TR SC III 
EMER.LSCS- FETAL 
DISTRESS M 3 T - ANEMIA - Cu-T 
237 SRIDEVI 33 13099 G3P1L1A1 IV B trivial MR SC III 
EMER.RPT.LSCS- 
PREVLSCS/ BREECH F 3 T - ANEMIA/ HBsAg POSITIVE - LSCS-ST 
238 SARASWATHI 23 8226 PRIMI IV B VIRAL MYOCARDITIS SC I LABOUR NATURALE  M 2.8 T CCF/ DEATH CHICKEN POX/ DEATH - - 
239 GEETHA 29 1293 PRIMI III B 
PRIMARY 
PULMONARY 
HYPERTENSION SC IV 
POSTMORTEM 
CAESAREAN F 1.4 PT CCF 
CIRRHOSIS OF LIVER/ 
PORTAL HYPERTENSION/ 
HELLP SYNDROME/ DEATH IUD - 
240 DEEPIKA 23 6909 PRIMI III B mild valvular PS SC I 
ELECTIVE LSCS -
OBLIQUE LIE F 2.9 T - 
DEAF, MUTE, BICORNUATE 
UTERUS - Cu-T 
241 YUVARANI 27 20680 G2P1L1 IV B mild MR SC III LABOUR NATURALE  M 3 T - 
DEAF,MUTE,ABNORMAL 
GAIT - Cu-T 
242 RAJALAKSHMI 32 1571 G2P1L0 V B critical MS/ PHT SC IV 
ELECTIVE RPT LSCS-
PREV LSCS/ CPD M 2.3 T 
ACUTE 
PULMONARY 
EDEMA DEATH SGA - 
243 KALAIMAGAL 21 6748 PRIMI IV B 
large 
perimembranous 
VSD/ severe PHT SC IV LABOUR NATURALE  F 1.5 PT 
PULMONARY 
EMBOLISM  DEATH RDS/ EXPIRED - 
244 MALAR 32 21237 G3P2L2 V B 
critical MS/ mild TR/ 
severe PHT SC IV OUTLET FORCEPS F 1.25 T 
ATRIAL 
FIBRILLATION/ CCF DEATH EXPIRED - 
245 RADHADEVI 30 33148 PRIMI IV B 
PERIPARTUM 
CARDIOMYOPATHY SC IV 
EMER.LSCS-FETAL 
DISTRESS F 2.7 T CCF DEATH - - 
246 DURGA 21 38431 PRIMI IV B 
PRIMARY 
PULMONARY 
HYPERTENSION SC IV 
SPONTANEOUS 
EXPULSION M 0.7 PT CCF DEATH EXPIRED - 
247 USHA  24 2597 G2P1L1 V B ASD SC IV 
EMER.RPT.LSCS-
PREV.LSCS/ CPD M 2.75 T 
SUPRAVENTRICULA
R TACHYCARDIA  DEATH - LSCS-ST 
248 MENAKA 21 5115 PRIMI V B 
PRIMARY 
PULMONARY 
HYPERTENSION SC IV OUTLET FORCEPS F 2.1 T CCF DEATH - - 
249 PAVITHRA 20 10280 PRIMI V B 
ELLIS VAN CREVELD 
SYNDROME P IV LABOUR NATURALE  M 1 PT CCF DEATH IUD - 
250 ANANDHI 23 24239 PRIMI IV B MVPS SC II 
EMER.LSCS-FETAL 
DISTRESS M 3.3 T - EPILEPSY - Cu-T 
251 SARANYA 19 4373 PRIMI V B MVPS OF AML SC III LABOUR NATURALE  M 1.7 PT - FEVER RDS - 
252 VANAJA 24 24644 G3P2L1 V B 
severe MS/ 
MR/TR/PHT SC IV LABOUR NATURALE  M 1.7 PT CCF FEVER/LRI EXPIRED - 
253 KAMALESHNI 23 738 PRIMI V B mild MR/ MVPS SC II OUTLET FORCEPS M 3.25 T - GDM - Cu-T 
254 UMASHREE 20 792 G2A1 IV B 
DILATED 
CARDIOMYOPATHY SC III OUTLET FORCEPS F 2.5 T - GDM - Cu-T 
  
 
255 ARUNA 26 17553 G2P1L1 IV B ASD/ mild TR SC III 
EMER.RPT.LSCS-
PREV.LSCS/ CPD M 2.6 T - GDM/ GHT - Cu-T 
256 NARMADHA 31 11448 PRIMI V B severe MVPS/ MR SC III 
EMER.LSCS- CPD/ 
FAILED ACCELERATION F 3.2 T - GDM/ INFERTILIITY - Cu-T 
257 SARASWATHI 24 6402 G2P1L1 IV B 
2nd DEGREE HEART 
BLOCK SC III OUTLET FORCEPS M 2.6 T - GDM/GHT RDS Cu-T 
258 JAYANTHI 27 85421 G3P2L1 IV B 
trivial MR/ TR/ severe 
PHT SC III 
ELECTIVE RPT LSCS-
PREV LSCS/ CPD F 2.75 T - GHT - LSCS-ST 
259 MERLLIN 26 10998 PRIMI V B  IAS ANEURYSM/ ASD SC III OUTLET FORCEPS M 2.8 T - GHT - Cu-T 
260 REGINA 33 33322 PRIMI IV B PS SC II OUTLET FORCEPS M 1.8 PT - GHT RDS Cu-T 
261 NIRMALA 24 37958 PRIMI IV B mild MR/ TR SC II LABOUR NATURALE  F 3 T - GHT - Cu-T 
262 MALATHI 26 12630 PRIMI V B MVPS/ trivial MR SC II 
EMER.LSCS- FETAL 
DISTRESS F 2.85 T - GHT - Cu-T 
263 CHITHRA 24 14961 PRIMI IV B mild MR SC II LABOUR NATURALE  F 2.25 T - GHT - Cu-T 
264 RAMYA 28 7656 G3P2L1 IV B MR SC III 
EMER.RPT.LSCS-CPD/ 
ABRUPTIO GR.II M 2.5 T - GHT/ ABRUPTION GR II IUD - 
265 JAYANTHI 39 2466 G2A1 V B MR SC III 
EMER.LSCS- LONG 
PERIOD OF 
INFERTILITY/ CPD 
MAJOR F 2.5 T - GHT/ HYPOTHYROID - Cu-T 
266 CHANDRIKA 23 31255 PRIMI V B 
moderate to severe 
MS / severe PHT SC IV LABOUR NATURALE  M 2.3 T 
ACUTE 
PULMONARY 
EDEMA GHT/DEATH IUD - 
267 POONGODI 22 10442 PRIMI IV B 
severe MS/ moderate 
PHT SC IV OUTLET FORCEPS M 1.7 PT 
ACUTE 
PULMONARY 
EDEMA H1N1 POSITIVE/ DEATH RDS - 
268 AMUL 27 5839 G2P1L0 IV B 
severe MS/ moderate 
MR/ POST CMC SC III 
EMER.LSCS-
BREECH/BOH F 2.5 T - HYPERTHYROID - Cu-T 
269 JOTHI 24 7458 PRIMI V B 
1ST DEGREE HEART 
BLOCK SC II EMER.LSCS-CPD MAJOR F 3.5 T - HYPOTHYROID - Cu-T 
270 YASMINE 25 13757 G2P1L1 V B 
MVPS/ moderate MR/ 
PHT SC II 
ELECTIVE RPT LSCS-
PREV LSCS/CPD M 2.5 T - HYPOTHYROID - LSCS-ST 
271 PRAVEENA 23 2493 G2A1 V B ASD CLOSURE DONE SC II LABOUR NATURALE  M 2.25 T - HYPOTHYROID RDS Cu-T 
272 SUMATHI 24 7424 G2P1L1 IV B MR SC III 
EMER.LSCS-FETAL 
DISTRESS M 2.7 T - LRI - LSCS-ST 
273 BABY 25 34841 G5P4L3 V UB severe MS/ PHT SC IV 
EMER.LSCS-FLEXED 
BREECH M 1.9 PT CCF LRI - LSCS-ST 
274 VIOLAJEBAKUMARI 24 9166 PRIMI IV B 
VSD/ SUBPULMONIC 
STENOSIS  SC III OUTLET FORCEPS M 2.5 T - MILD ATONIC PPH - - 
275 KOWSALYA 26 14681 G2P1L1 V B MVPS/ MR SC III LABOUR NATURALE  F 2.25 T - mild PRE-ECLAMPSIA - PS 
276 KAVITHA  27 12937 G2P1L1 IV B severe MR SC II 
EMER.LSCS-FETAL 
DISTRESS F 3.2 T - MRO - LSCS-ST 
  
 
277 VIJAYA 20 20072 PRIMI IV B 
CONSTRICTIVE 
PERICARDITIS SC IV UNDELIVERED - - - CCF 
OESOPHAGEAL 
VARIES/HEMORRHAGIC 
SHOCK/ DEATH - - 
278 SULOCHANA 22 4152 PRIMI V B MR SC III OUTLET FORCEPS M 2.8 T - OLD CVA - Cu-T 
279 VIGNESWARI 32 8341 PRIMI V B 
moderate MR/ mild 
TR SC III 
EMER.LSCS- APH / 
FETAL DISTRESS F 1.7 PT - 
PLACENTA PREVIA/ 
HYPOTHYROIDISM RDS - 
280 KRISHNAVENI 27 17355 G2A1 IV B 
MVPS/ trivial TR/ 
trivial MR SC II 
ELECTIVE LSCS-FLEXED 
BREECH M 2.7 T - POLYHYDRAMNIOS - Cu-T 
281 LAKSHMIPRIYA 23 13666 PRIMI III B ASD SC I 
ASSISSTED BREECH 
DELIVERY M 0.8 PT - PPROM  EXPIRED - 
282 SANGEETHA 25 9481 G2A1 IV B 
TGA CORRECTED/ 
small VSD SC III LABOUR NATURALE  M 1.8 PT - 
PPROM/MANUAL 
REMOVAL OF PLACENTA RDS/ EXPIRED - 
283 KAVITHA  24 3963 PRIMI IV B 
DILATED 
CARDIOMYOPATHY SC IV 
SPONTANEOUS 
EXPULSION M 0.9 PT CCF 
PRE ECLAMPSIA/ 
BRONCHIAL ASTHMA IUD - 
284 PREETHI 20 8510 G2A1 V B MVPS of AML SC IV VACCUM EXTRACTION F 2.3 PT 
ACUTE 
PULMONARY 
EDEMA 
PRE ECLAMPSIA/ PPROM/ 
DEATH IUD - 
285 KUMARI  24 24369 G2P1L1 V B MR SC I 
EMER.RPT LSCS-
PREV.LSCS/PROM M 3 T - PROM - LSCS-ST 
286 VEERALAKSHMI 24 26054 PRIMI V B 
moderate MR/ AR/ 
TR/PHT SC II LABOUR NATURALE  M 2.75 T - PROM - - 
287 SORNAM  28 29450 G3P1L1A1 IV B mild MR/ TR/ PHT SC II 
EMER.RPT LSCS-
PREV.LSCS/PROM M 3.25 T - PROM - LSCS-ST 
288 BHAVANI 26 35160 PRIMI IV B ASD/ VSD/ MR SC II OUTLET FORCEPS M 2.775 T - PROM - - 
289 GANESHRANI 26 3419 G3A2 V B 
severe MS/ mild MR/ 
PHT/ MVR DONE SC IV 
EMER.LSCS- PROM/ 
OLIGOHYDRAMNIOS M 2.5 T 
ATRIAL 
FIBRILLATION/ CCF PROM - - 
290 SIVASHANKARI 22 10607 PRIMI V B moderate MS/ MR SC II 
EMER.LSCS- SEVERE 
OLIGOHYDRAMNIOS F 2.5 T - PROM - PS 
291 GANGA 22 11571 PRIMI V B mild MR/ AR SC II 
EMER.LSCS- SEVERE 
OLIGOHYDRAMNIOS F 2.7 T - PROM - - 
292 SHOBANA 24 12619 G3P1L1A1 V B MS/ PHT  SC II 
EMER.LSCS- FAILED 
INDUCTION F 2.75 T - PROM - LSCS-ST 
293 NOORJAHAN 27 10978 PRIMI III B PDA/mild MR SC II 
EMER.LSCS-FETAL 
DISTRESS M 3.3 T - Rh- NEGATIVE - Cu-T 
294 NATHIYA 24 14258 G2P1L1 IV B MVPS SC I LABOUR NATURALE  M 3.1 T - Rh- NEGATIVE - - 
  
 
295 SHENBAGAVALLI 22 13603 PRIMI IV B severe MS/ mild PHT SC IV OUTLET FORCEPS M 2.4 T 
ACUTE  
PULMONARY 
EDEMA/ CMC 
DONE Rh- NEGATIVE - Cu-T 
296 MALLIGA 29 28148 PRIMI IV B severe MS/ PHT SC III 
EMER.LSCS-FETAL 
DISTRESS M 2.75 T - Rh- NEGATIVE - Cu-T 
297 NOORJAHAN 37 37182 G2P1L1  III B ASD/ VSD OPERATED SC I 
EMER.RPT.LSCS-
PREV.LSCS/ CPD M 3.9 T - Rh- NEGATIVE - LSCS-ST 
298 GOMATHI 28 1127 G2P1L1 V B severe MS/ mildPHT SC III OUTLET FORCEPS F 2.3 T - Rh- NEGATIVE - Cu-T 
299 ARCHANA 28 5978 G4P1L1A2 V B ASD CLOSURE DONE SC I LABOUR NATURALE  M 3.1 T - Rh- NEGATIVE MAS Cu-T 
300 LAKSHMI 22 12325 G2P1L1 V B mild MR SC I LABOUR NATURALE  M 3.2 T - Rh- NEGATIVE - - 
301 SARASWATHI 22 4095 G3P1L1A1 IV UB 
moderate MS/severe 
MR/severe 
AR/pericardial 
effusion SC IV 
VBAC/ASSISSTED 
BREECH DELIVERY F 1.3 PT CCF SEVERE ANEMIA RDS/ EXPIRED Cu-T 
302 KAMALA  21 34469 G2P1L0 V B ASD CLOSURE DONE SC II 
EMER.LSCS-CPD/FAILED 
ACCELERATION F 3.5 T - UTI - Cu-T 
 
 
 
 
 
 
 
 
 
  
 
1 NAME AGE IP NO PARITY INDEX SES TYPE OF HEART DISEASE NYHA CLASS TRIMESTER PURPOSE OF MTP PROCEDURE COMPLICATIONS 
2 DEEPA 24 10052 G3P2L2 IV ASD I I COMPLETED FAMILY MVA/ TAT - 
3 SELVI 24 70 G2P1L1 V ASD/ mild PHT III I HEART DISEASE MVA/ TAT - 
4 SELVI 25 125 G2P1L1 IV ASD/ mild PHT II  I HEART DISEASE MVA/ CuT - 
5 KALASRI 32 728 G2P1L1 IV critical MS/ PHT II I HEART DISEASE MVA/ CuT - 
6 JAMUNA 31 2481 G3P2L2 V 
DILATED 
CARDIOMYOPATHY I I COMPLETED FAMILY MVA/ TAT - 
7 SARGUNAM 38 2328 G8P6L5A1 V 
EISENMENGER 
SYNDROME II I COMPLETED FAMILY MVA/ TAT - 
8 CHITHRA 23 1334 G2P1L1 IV 
III DEGREE HB- 
PACEMAKER II I HEART DISEASE MVA/ TAT - 
9 NADHIYA 23 1239 G2P1L1 IV mild MR III I HEART DISEASE MVA/ TAT - 
10 RAJI 32 1202 G3P2L2 V mild MR II I COMPLETED FAMILY MVA/ TAT - 
11 TAMILMANI 27 1576 G2P1L1 IV sev. MR/ MS/ AR IV I PLANNED FOR MVR MVA/ TAT - 
12 LINGAJOTHI 33 1515 G5P3L3A1 IV mild MS/ MR IV I HEART DISEASE MVA/ TAT - 
13 MALAR 38 2337 G4P2L2A1 V mode. MR II I COMPLETED FAMILY MVA/ TAT - 
14 SUJATHA 29 2401 G3P2L2 III mode. MR/ AR/ PS III I COMPLETED FAMILY MVA/ TAT - 
15 RAJESWARI 30 2747 G3P2L2 IV mode. MR/ mild PS/ PHT II I COMPLETED FAMILY MVA/ TAT - 
16 CHITHRA 39 2801 G2P1L1 III mode. MR/ mild PS/ PHT II I HEART DISEASE MVA/ TAT - 
17 ANJALI 35 2817 G3P2L1 IV 
mode. MS/MR/AR/ sev. 
PHT III I HEART DISEASE MVA/ TAT - 
18 RAJESWARI 24 2891 G3P2L2 V 
mode. MS/ MR/ AR/ mild 
TR II I COMPLETED FAMILY MVA/ TAT - 
19 PRABAVATHY 28 2902 G3P2L1 IV mode. MS/ PHT III I HEART DISEASE MVA/ TAT - 
20 JAYANTHI 26 2972 G3P2L2 V MR/ TR III I COMPLETED FAMILY MVA/ TAT - 
21 MANI 30 5834 G3P2L2 IV MS/ MR IV I PLANNED FOR BMV MVA/ TAT - 
22 SARALA 26 5886 G3P2L2 III MS/ MR/ CMC DONE II I COMPLETED FAMILY MVA/ TAT - 
23 SHANTHI 26 6209 G2P1L1 IV MS/ MR/ MVR DONE IV I COMPLETED FAMILY MVA/ CuT - 
24 VADHANI 27 7124 G4P3L3 V MS/MR/PHT IV 
I 
PLANNED FOR CMC MVA/ TAT - 
25 SANGEETHA 20 6057 G2P1L1 III MVPS I I HEART DISEASE MVA/ LS - 
  
 
26 LAKSHMI 28 7283 G3P2L2 IV MVPS/ MR III II HEART DISEASE MTP/ TAT - 
27 SHARMILI 28 7363 G2P1L1 IV MVPS/ MR II I HEART DISEASE MVA/ LS - 
28 SHAHIDHA 26 9463 G3P2L2 V PDA III I HEART DISEASE MVA/ TAT - 
29 SUMATHI 24 9263 G3P2L2 IV sev. MR III I HEART DISEASE MVA/ TAT - 
30 SELVI 28 9268 G4P3L3 V sev. MR/ POST MVR IV I HEART DISEASE MVA/ TAT Afi 
31 SUMATHI 29 258 G3P2L2 IV sev. MS/ MR/ AS/ AR II I COMPLETED FAMILY MVA/ TAT - 
32 UMAMAHESWARI 22 531 G4P1L1A2 IV sev. MS/ MR/PHT I I HEART DISEASE MVA/ TAT - 
33 TAMILSELVI 25 499 G3P2L2 IV sev. MS/ PHT I I COMPLETED FAMILY MVA/ TAT - 
34 SHANTHI 20 1607 G2P1L1 III sev. MS/ PHT II I HEART DISEASE MVA/ CuT - 
35 GOMATHI  22 2704 G2P1L1 IV sev. MS/ PHT II I HEART DISEASE MVA/ CuT - 
36 AKILA 19 3241 PRIMI II  sev. MS/ PHT II I HEART DISEASE MVA/ CuT - 
37 LATHA 25 4892 G3P2L2 IV sev. PHT / VSD III I COMPLETED FAMILY MVA/ TAT - 
 
 
 
 
 
 
 
  
 
 
KEY TO MASTER CHART 
MS : Mitral Stenosis 
MR : Mitral Regurgitation  
AR : Aortic Regurgitation 
AS : Aortic Stenosis 
TR : Tricuspid Regurgitation 
CMC : Closed Mitral Commissurotomy 
BMV : Ballon Mitral Valvuloplasty. 
MVR : Mitral Valve Replacement 
OMV : Open Mitral Valvotomy. 
MOD : Moderate 
SEV : Severe 
GPLA : Gravida, Para, Live, Abortion. 
B.WT : Birth Weight 
IUD : Intrauterine Death 
CPD : Cephalo Pelvic Disproportion 
MVA : Manual Vacuum Aspiration 
TAT : Trans Abdominal Tubectomy 
LS : Laparoscopic Sterilisation 
MTP : Medical Termination of  Pregnanc
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
CONSENT FORM 
STUDY TITLE: 
STUDY OF MATERNAL AND PERINATAL OUTCOME IN HEART 
DISEASE COMPLICATING PREGNANCY IN A TERTIARY INSTITUTION. 
STUDY CENTRE: 
  INSTITUTE OF OBSTETRICS AND GYNAECOLOGY, Egmore, 
Chennai-600008 
PARTICIPANT NAME:                                      AGE:      SEX:     LD NO:  
I confirm that I have understood the above study. I have the opportunity to 
ask. The question and all my questions and doubts have been answered to my 
satisfaction. 
                    I understand that my participation in the study is voluntary and that I 
am free to withdraw at any time without giving any reason. 
I understand the investigator, regulatory authorities and the ethics 
committee will not need my permission to look at my health records both in 
respect to the current study and any further research that may be conducted in 
relation to it, even if I withdraw from the study. I understand that my identity will 
not be revealed in any information released to third parties of published, unless as 
required under the law. I agree not to restrict the use of any results that arise from 
the study. 
 I hereby consent to consent to participate in this study titled “STUDY OF 
MATERNAL AND PERINATAL OUTCOME IN HEART DISEASE 
COMPLICATING PREGNANCY IN A TERTIARY INSTITUTION” 
 
Signature of investigator:                                                               Place: 
 
Study investigator’s name:                                                            Date: 
 
Signature / thumb impression of patient: 
  
